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CHARACTERIZATION OF POTENTIAL INTERACTIONS BETWEEN TRANSFERRIN 
BINDING PROTEINS IN NEISSERIA GONORRHOEAE 
 
By Shreni Dilipkumar Mistry 
 
A dissertation submitted in partial fulfillment of the requirements for the degree of  
Doctor of Philosophy at Virginia Commonwealth University 
 
Virginia Commonwealth University, 2013 
 
Major Director: Cynthia Nau Cornelissen, Ph.D. 
Professor of Microbiology and Immunology 
 
 
Neisseria gonorrhoeae requires iron for survival and establishment of infection in the 
human host.  Pathogenic Neisseriae have evolved a repertoire of high-affinity iron acquisition 
systems to facilitate iron uptake in the human host. This requires specific outer membrane 
receptors and energy-harnessing cytoplasmic membrane proteins. The transferrin receptor 
proteins of Neisseria gonorrhoeae are necessary for iron uptake from transferrin in the host. The 
iron uptake system consists of two transferrin binding proteins, (Tbp) A and B. TbpA is an 
xvi 
 
integral outer membrane, TonB-dependent transporter that forms the pore for iron 
internalization. TbpB is a surface exposed lipoprotein that makes the iron internalization process 
more efficient.  
TbpA is proposed to consist of two distinct domains: a β barrel and an N-terminal plug 
domain. Previous studies have shown that the EIEYE sequence in the TbpA plug domain plays 
an important role in iron internalization. We undertook a collaborative project to test the 
hypothesis that the conserved EIEYE sequence in the wild-type TbpA plug binds Fe
3+
 during the 
outer membrane iron transport process. CD spectra analysis and fluorescence emission titration 
spectra of purified recombinant wildtype and mutated plug proteins revealed that Fe
3+ 
 is 
sequestered by the wildtype TbpA plug protein, unlike the mutated plug protein. Modeling data 
with the wild-type plug predicts the EIEYE sequence is part of a flexible loop structure and acts 
as an Fe
3+
 binding site. 
Characterization of the Tbps constituting the gonococcal receptor is important to 
understanding how the gonococcus survives within its host. TbpA and TbpB act together to 
acquire iron from human transferrin. We hypothesize that the presence of TbpA impacts the 
exposure or conformation of TbpB. In this study, we have utilized photoactivable cross-linkers to 
assess the effect of TbpA on TbpB in live gonococcal cells and studied it in presence of ligand 
and TonB derived energy. We employed insertion mutants, in which TbpA and TbpB contained 
the hemagglutinin (HA) epitope tag, to probe for impact of TbpA on TbpB. Our results 
demonstrate that photo-cross-linking altered TbpB size and migration and was dependent on the 
presence of TbpA. HA epitope insertion mutants in surface exposed loops of TbpA and TbpB did 
not impact the mobility of cross-linked TbpB. Addition of human transferrin to the de-energized 
xvii 
 
mutant caused a change in TbpB migration after cross-linking. This result indicates that when 
ligand is bound tightly and irreversibly to de-energized TbpA, the surface accessibility and 
perhaps conformation of TbpB is altered and TbpA does not interact with TbpB. Our findings 
were confirmed with recent structural studies of TbpA-TbpB-ligand triple complex, which 
illustrate that Tbps bind ligand through unique, non-overlapping binding sites such that TbpA 
and TbpB do not interact.  
TbpB is not an essential member of transferrin-iron acquisition pathway. It is surface 
exposed and tethered to the outer membrane by a lipid moiety. The role of TbpB has not been 
clearly outlined in the transferrin iron acquisition system. The last objective of this study was to 
look at the significance of two specific conserved regions of TbpB and its importance in 
transferrin iron utilization and TbpA-TbpB interaction. Using site-directed mutagenesis we 
created two mutants, in the first mutant the conserved lipobox of TbpB was replaced with a 
signal I peptidase cleavage site, and the second mutant contained a deletion of the conserved 
poly glycine residue stretch, immediately downstream of the lipobox. Our results indicate that 
lipobox is required for lipidation of TbpB, both the mutants were impaired for transferrin-iron 
utilization, and neither of the mutations altered TbpA-TbpB interaction. 
Overall, these studies help elucidate the functional importance of the specific regions in 
TbpA and TbpB in Neisseria gonorrhoeae, thereby adding to our understanding of the process of 
iron acquisition through the transferrin binding proteins.
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CHAPTER 1: INTRODUCTION 
 
I. The family Neisseriaceae 
Historically, the family Neisseriaceae is comprised of four genera Neisseria, 
Moraxella, Kingella, and Acinetobacter (21, 101, 219, 220). These four genera are 
classified as Gram-negative and differentiated from each other based on cell 
morphology, presence of oxidase, catalase, thymidine kinase, carbonic anhydrase, 
acid production from glucose, and nitrite reduction (Table 1). The microorganisms 
included in these four genera are medically significant to humans as pathogens and or 
commensals.  
 
II. The Genus Neisseria 
Albert Neisser discovered Neisseria gonorrhoeae in 1897 (219) and the genus 
Neisseria was named after him (219). Following this discovery, N. meningitidis was 
isolated by Weischelbaum in 1887, N. sicca, N. mucosa, and N. subflava were 
isolated by Ligenlsheim in 1906, and N. flavescens was discovered by Branhman in 
1930 (219).  
The Neisseria species are Gram-negative, non-motile, non-spore forming cocci, 
found in pairs. Depending on the species, age of cultures, and source of the isolate, 
individual cells of Neisseria may range from 0.6 to 1.5 µm in size. These are 
fastidious microorganisms, requiring complex growth media. They are aerobic or 
facultative aerobic and grow best between 35-37
o
C in a humidified atmosphere of 5-
10% CO2. Neisseria species are differentiated on the biochemical basis of production  
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Table 1. Characteristics of the genera included in the Family Neisseriaceae 
 
Characteristics Genus 
 Neisseria Kingella Moraxella Acinetobacter 
Cell Morphology Diplococci* Cocobacilli Rods Rods 
Oxidase + + + - 
Catalase + - + - 
Acid production from 
Glucose 
+ + - +/- 
Nitrite reduction + + - - 
 
*exception is N. elongata, it is rod-shaped  
This table has been adapted from CDC (38) 
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of acid from carbohydrates and nitrite reduction. This genus includes species that are 
commensals or human pathogens, as illustrated in Table 2. Most of these Neisseria 
species are found in the mucous membranes of the respiratory and urogenital tracts. 
The Neisseria species can be divided into two broad groups; the pathogenic and 
the non-pathogenic. The two important human pathogens are Neisseria gonorrhoeae 
and Neisseria meningitidis. These two pathogens are closely related genetically (209), 
despite expressing some of the same virulence factors, the diseases caused by them 
are different.  Neisseria meningitidis is the causative agent of bacterial meningitis and 
severe sepsis, and Neisseria gonorrhoeae is the principle agent of the sexually 
transmitted infection, gonorrhea.  
 
III. Diseases caused by Neisseria species 
 
A. Meningococcal Disease- Infection and Epidemiology 
Meningococcal disease can occur as epidemic or endemic cases. N. 
meningitidis serogroup A has caused major epidemics of meningitis in Africa with 
periodic epidemics occurring in the Sub-Saharan African region, especially in the 
'meningitis belt' (200).  Neisseria meningitidis is  a common commensal, isolated 
from the nasopharynx of 8–20% of healthy individuals (92, 200). The duration of 
carriage is variable (approximately 4 months), with differences being observed 
between different N. meningitidis serogroups (108). The carriage strains are more 
widespread in nature than disease-causing strains and N. meningitidis is an occasional 
pathogen, as sometimes during the bacteria-host interaction meningococcal disease is   
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Table 2: Characteristics of Human-Associated Neisseria Species 
 
I) N. meningitidis occurs in carrier state, with some serogroups causing epidemics/pandemics 
II) N. flavescens was isolated from an outbreak of meningitis. There have been no reliable descriptions of isolation of this species, apart from the original 
description. 
 
Table adapted from CDC (38) 
Species 
Acid production from 
Polysaccharide from 
Glucose 
Reduction of 
Nitrate 
Association with 
Humans  
Glucose Maltose Sucrose Fructose Lactose 
 
         
 N. gonorrhoeae Y N N N N N N Pathogen 
 
         
 N. meningitidis Y Y N N N N N I 
 
         
 N. lactamica Y Y N N Y N N Commensal 
 
         
 N. cinerea N N N N N N N Commensal 
 
         
 N. polysaccharea Y Y N N N Y N Commensal 
 
         
 N. subflava Y Y N N N N N Commensal 
 
         
 N. sicca Y Y Y Y N Y N Commensal 
 
         
 N. mucosa Y Y Y Y N Y Y Commensal 
 
         
 N. flavescens N N N N N Y N II 
 
         
 N. elongata N N N N N N N Commensal 
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an accidental outcome (208). Meningococcal disease incidence varies in human 
populations from rare to over 1000/100,000 population/year. Meningococcal disease 
occurs as sporadic cases, localized outbreaks and case clusters, and epidemic and 
pandemic disease (144). 
Structural differences in capsular polysaccharide, lipo-oligoscaachride and outer 
membrane proteins help in characterizing and classifying the meningococci into 
different serogroups and serotypes.  There are 13 diverse polysaccharide capsules but 
only A, B, C, W-135, and Y commonly cause invasive infections (78).  The highest 
incidence of meningococcal disease occurs in the meningitis belt of sub-Saharan 
Africa. During epidemics, the incidence can approach 1000 cases per 100,000 
population, or 1% of the population. Serogroup A has been the most important 
serogroup in this region. However, serogroup C and X mediated disease has also 
occurred (76, 78, 233). 
In the Americas, the reported incidence of disease is in the range of 0.3-4 cases 
per 100,000 population, which is much lower than in the meningitis belt. The bulk of 
the disease in the Americas is caused by serogroups C and B, although serogroup Y 
causes a substantial proportion of infections in some countries and W-135 is 
becoming increasingly problematic as well (26, 40). The majority of meningococcal 
disease in European countries, which ranges in incidence from 0.2 to 14 cases per 
100,000, is caused by serogroup B strains (201). 
N. meningitidis is a frequent asymptomatic colonizer of the human upper 
respiratory tract, and is carried in the nasopharynx by 5-15% of healthy adults and 
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children and it may be acquired through the inhalation of respiratory droplets (26, 35, 
213). The organism establishes intimate contact with non-ciliated mucosal epithelial 
cells of the upper respiratory tract, where it may enter the cells briefly before 
migrating back to the apical surfaces of the cells for transmission to a new host.  
In susceptible individuals, once in the blood, N. meningitidis may survive, 
multiply rapidly and disseminate throughout the body and into the CSF (26, 146). 
Meningitis occurs when bacteria interact with the endothelial cells of the brain 
microvessels and cross the blood-brain barrier. Symptoms develop within 1–14 days 
of acquisition and include fever, nausea, headache, purpura, petechiae, photophobia, 
stiff neck, and change in mental status (221). Less common manifestations of 
meningococcal disease include septic arthritis, pneumonia, purulent pericarditis and 
conjunctivitis, among others (33, 202). Serious infections are usually manifested as 
meningitis and septicaemia (33, 237) Meningococcal sepsis, which is also called 
meningococcemia, occurs in only 5 to 20 percent of patients. Meningococcemia is 
characterized by an abrupt onset of fever and purpuric rash. (179). The overall case 
fatality rates over the past 20 years have been at 9 to 12 percent, with a rate of up to 
40 percent among patients with meningococcal sepsis.  Eleven to 19 percent of 
survivors sustain permanent sequelae including deafness and mental retardation 
(179). 
The outcomes of meningococcal infection may be devastating and, in the absence 
of timely intervention, can lead to neurological disorders and death. For management 
of the disease the recommended treatment includes administration of antibiotics like 
penicillin or ceftriaxone (35, 179).  Due to the high rates of morbidity and mortality 
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associated with meningococcal disease and increasing antibiotic resistance, for 
prevention control, two vaccines are available in the United States. They are (i) 
MCV4-a meningococcal conjugate vaccine, where cell surface polysaccharides from 
serogroups A, C, Y and W-135 are conjugated to diphtheria toxoid; and (ii) MPSV4- 
a meningococcal polysaccharide vaccine against serogroups A, C, Y, and W-135 
(26). The ultimate control of meningococcal disease requires widespread surveillance, 
the expanded use of polysaccharide conjugate vaccines, and the development of 
broadly effective serogroup B vaccines to prevent this microorganism from posing as 
a major threat to human health in industrialized countries. 
 
B. Gonococcal Disease- Infection and Epidemiology 
Gonorrhoea is a global health concern and cause of serious reproductive 
complications in women. After chlamydia, gonorrhea is the second most commonly 
reported notifiable disease in the United States (36, 37). In 2011, a total of 321,849 
cases of gonorrhea were reported in the United States, yielding a rate of 104.2 cases 
per 100,000 population, increasing the rate by 4.0% since 2010 (36). In reality these 
numbers are thought to be under-represented due to under-reporting and 
asymptomatic infection. In 2011, persons aged 15–44 years accounted for 94.6% of 
reported gonorrhea cases, with the highest rates observed among women and men 
aged 20-24 years. Gonorrhea rates were higher in women than in men and the African 
American community showed gonorrhea infection rates that were 4-5 times the 
national average with a rate of 427.3 cases per 100,000 population (33, 36). 
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N. gonorrhoeae is the causative agent of the sexually transmitted infection 
gonorrhoea. N. gonorrhoeae is transmitted through close sexual contact with infected 
individuals, and vertical transmission occurs when the gonococcal infection is passed 
from mother to her newborn during childbirth. N. gonorrhoeae primarily infects the 
urethral epithelium in males (2, 46) and the ectocervial and endocervical epithelium 
in females (65). Secondary infections can occur in the rectum, conjunctiva and the 
pharynx (66). In men, symptoms typically begin 2-5 days after infection, 
characterized by purulent urethral discharge and dysuria. Secondary infections occur 
as bacteria ascend the upper genital tract to cause epididymitis, prostatitis, and 
urethritis. Approximately 10 days after infection, women infected with N. 
gonorrhoeae, experience cervicitis/urethritis, causing increased vaginal discharge, 
dysuria and menstrual abnormalities. (17, 87, 102, 196). It is estimated that as many 
as 80% of infected females are asymptomatic (197). This makes diagnosis difficult 
and leads to almost half of the infected females developing ascending gonococcal 
infections. If left untreated this can lead to serious downstream sequelae such as 
pelvic inflammatory disease (PID), resulting in scarring of the fallopian tubes, ectopic 
pregnancies, and infertility (149, 207). It is estimated that 10% of women suffer from 
PID (3, 66). Dissemination of the gonococci into the bloodstream results in 
disseminated gonococcal infection (DGI), though it is less common and occurs in 0.5-
3% of infected individuals. DGI can cause arthritis-dermatitis syndrome, endocarditis, 
sepsis or meningitis in rare cases (66, 174, 197). 
Gonorrhea treatment has been complicated by the ability of N. gonorrhoeae to 
develop resistance to antimicrobials used for treatment. Gonorrhea has progressively 
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developed resistance to the antibiotic drugs prescribed to treat it. In the past 
gonorrhoea was treatable with single-dose treatment with penicillin or streptomycin; 
however by 1958 resistance had been reported (156). By 1986, the CDC reported that 
over 22% of all isolates collected by gonococcal isolate surveillance project (GISP) 
were resistant to tetracycline and or penicillin (103). In 1993, fluoroquinolones and 
cephalosporins (ceftriaxone and cefixime) were the recommended treatments for 
gonorrhea. In the early 2000s ciprofloxacin resistance was detected among men who 
have sex with men (MSM) with gonorrhea. By 2006, 13.8% of isolates exhibited 
resistance to ciprofloxacin. On April 13, 2007, CDC stopped recommending 
fluoroquinolones as treatment for gonococcal infections for all persons in the United 
States (33, 34, 36). In 2011, 30.4% of isolates collected in GISP were resistant to 
penicillin, tetracycline, ciprofloxacin, or a combination of these antimicrobials. The 
effectiveness of cefixime for treating gonorrhea is declining, which has made CDC 
update its gonorrhea treatment guidelines. CDC no longer recommends the routine 
use of cefixime. CDC now recommends using ceftriaxone to treat gonorrhea (61). 
The first known failure of ceftriaxone and cefixime to successfully treat a case of 
gonorrhea reportedly occurred in Japan in 2003.The World Health Organization 
recently reported that a major public health crisis emerging, in the form of gonorrhea 
that doesn't respond to antibiotics. In 2009, the so-called gonorrhea "superbug" was 
found in Japan as well. It has been subsequently found at least once 
in Spain and France, but not yet in the U.S. (147, 214). Another cause for concern is 
the observation that gonococcal infection leads to increased transmission of the 
human immunodeficiency virus (HIV) (57, 72, 110). HIV transmission increases due 
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to the stimulation of viral HIV-LTR-dependent transcription by exposure to Neisseria 
gonorrhoeae (41). It has also been reported that in HIV infected individuals, 
concomitant infection with gonococci, leads to increased HIV shedding in genital 
secretions (45). These findings coupled with major rise in antibiotic resistance among 
Neisseria gonorrhoeae isolates make it critical to continuously monitor antibiotic 
resistance in Neisseria gonorrhoeae and encourage research, development and 
identification of alternative effective treatment regimens for gonococcal infections. 
IV. Gonococcal Virulence Factors 
For successful survival in the human host, gonococci express several cellular 
surface proteins that help in colonization and evasion of the host immune response. 
These surface proteins or virulence factors are subject to high frequency phase or 
antigenic variation, such that it offers several benefits to the bacterium. These 
virulence factors are discussed, to gain a greater understanding of the contribution of 
these virulence factors to successful gonococcal pathogenesis. A repertoire of 
virulence factors has been identified, which allow this bacterium to successfully adapt 
to variable microenvironments within its human host. This human adaptability and 
the repeated phase and antigenic change displayed by the gonococcus have hampered 
vaccine development. Many of the major virulence factors undergo phase and/or 
antigenic variation. 
A. Porin 
Porins are virulence proteins present in the outer membrane of the 
pathogenic Neisseria species, and are characterized by a trimeric β-barrel 
structure. Neisserial porins function by forming aqueous transmembrane 
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channels and they modulate the exchange of ions between the bacteria and the 
surrounding environment (66, 124). N. meningitidis expresses two types of 
porins, PorA and PorB. N. gonorrhoeae expresses only a PorB homolog; this 
is classified into two serotypes termed PIA and PIB (83). Gonococcal PorB is 
not subject to high frequency phase or antigenic variation (198), whereas 
meningococcal PorA is phase variable (216). 
Gonococcal porin can associate with G-actin, affect the kinetics of actin 
filament formation, and cause remodeling of preformed actin filaments, 
suggesting a role for this protein in the rearrangement of the actin 
cytoskeleton that occurs during the early stages of the infective process (228). 
It has been reported that gonococcal PorB has the ability to translocate into 
the eukaryotic cell membranes and form voltage-gated channels (modulated 
by ATP and GTP); this promotes invasion of host cells (14, 66, 118, 226).   
The neutrophil expression of immunoglobulin G (IgG) Fc receptors II and III, 
as well as the activation-dependent down regulation of Fc gamma RIII, were 
reduced by the meningococcal and gonococcal porins; they also inhibited the 
phagocytic capacity of neutrophils (12, 139). 
Gonococcal porins play an important role in enabling the bacteria to evade 
complement-mediated killing. The gonococcal porin PorB1A is critical in 
modulating stable serum resistance, which is not mediated by 
lipooligosaccharide (LOS) sialylation. Binding of factor H to PorB1A 
downregulates the alternative pathway of complement (124). It has been 
demonstrated that the N. gonorrhoeae porin PorB1B interacts with 
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mitochondria of HeLa cells and induces calcium efflux and caspase activity 
along with apoptosis (141, 142). 
 
B. Lipooligosaccharide (LOS) 
Most Gram-negative bacteria possess lipopolysaccharide (LPS) on their 
outer membrane. LPS of pathogenic Neisseria strains is comprised of a lipid 
A moiety, which anchors the molecule in the outer membrane, and a relatively 
short variable polysaccharide unit that lacks the repeating 0-antigens that are 
characteristic of the LPS of Gram-negative enteric bacteria (121, 218). The 
LOS undergoes high frequency antigenic variation. Glycosyl transferases add 
sugar residues to the core polysaccharide during LOS synthesis. These 
transferases contain poly G tracts within their genes, which enables them to 
undergo slip-strand mispairing, and resulting in the turning on or off of these 
genes. Altering the expression of these transferases leads to changes in LOS 
size and structure, due to variations in carbohydrate composition (27, 38, 58, 
66, 90).  LOS can also be modified using host derived cytidine 5’-mono-
phospho-N-acetyleneuraminic acid (CMP-NANA) found in human sera and 
secretions. CMP-NANA is used as the sialyl donor and membrane bound 
sialyltransferase mediate the process (121, 122).  
Neisseria are able to exhibit molecular mimicry through LOS, as they 
evade recognition as foreign by the host cells and affect cell function or even 
gain access to the cell interior (121). LOS sialylation makes it bind factor H, 
allowing the gonococcus to acquire serum resistance since complement 
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mediated killing via the alternate pathway is inhibited (167). Phase variation 
of LOS controls both bacterial entry into human mucosal cells, and bacterial 
susceptibility to killing by antibodies and complement (217). This reversible 
switch between cell-evasive to an immune-invasive phenotype helps the 
bacteria adapt to rapidly changing host environment.  LOS oligosaccharide 
side chains terminate in epitopes that mimic sugar moieties of mammalian 
glycosphingolipids. This form of molecular mimicry not only provides the 
bacterium with a method of immune avoidance but also allows the bacterium 
to use host-derived molecules that normally associate with the mimicked 
structure. 
 
C. Type IV Pilus 
The N. gonorrhoeae pilus protein is one of the major antigenic 
determinants on the gonococcal cellular surface. Gonococcal  pili  are surface  
appendages  composed  of  identical  polypeptide  subunits  termed  pilin,  
which polymerize  to  form  linear  structures, about 1,000-4,000  nm in 
length. The major structural subunit, the pilin or PilE protein, assembles into a 
helical pilus fiber and tip of the pilus is decorated with the adhesin, PilC (83). 
The pilus is a highly variable structure on the gonococcal surface; the pilin 
protein undergoes both antigenic and phase variation. Phase variation occurs 
during DNA replication in a RecA-independent manner.  The pilE gene has a 
poly C tract located at the beginning of the gene; during replication DNA 
polymerase can add/delete a C, thus causing frame-shifting and the gene to be 
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turned on or off  (105, 240). Multiple pil loci exist within the genome, 
antigenic variation occurs when high frequency, enabling recombination to 
occur between expressed pilE gene with many silent pilS gene copies (129, 
130). The pilE recombination event is non-reciprocal and RecA-dependent 
(77, 105, 189). Posttranslational modifications provide additional sources for 
PilE structural and functional diversity. Three distinct posttranslational 
modifications have been described; they include glycosylation (222), 
phosphoethanolamine modification (85), and phosphorylcholine modification 
(85, 227). 
 Several studies have suggested a role for PilE in receptor recognition, as 
different antigenic forms of PilE influence the adherence of Neisseria to 
epithelial cells and tissue tropism. Type IV pili of Neisseria gonorrhoeae 
and Neisseria meningitidis mediate the first contact to human mucosal 
epithelial cells, an interaction which is also critical for the interaction with 
vascular endothelial cells. Pili bind epithelial cell receptor molecules and 
thereby promote mucosal colonization.  They also interact with 
polymorphonuclear leukocytes and macrophages (104, 181, 184). An 
important factor in the pathogenesis of gonorrhea may be the ability of pili to 
facilitate attachment of N. gonorrhoeae by overcoming the initial electrostatic 
repulsive barrier that exists between the bacterial cell and the host cell (82).  
Type IV pili (Tfp) mediate the movement of bacteria over surfaces without the 
use of flagella. These movements are known as twitching motility (224).  
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Human volunteer infection studies have suggested a possible correlation 
between maintenance of virulence in association with piliation status of N. 
gonorrhoeae (95). Previous studies have suggested the cell surface protein CD46 
as a receptor for neisserial pili on human epithelial cells (93).  
However, recent studies point out pilus-mediated gonococcal infection of 
epithelial cells can occur in a CD46-independent manner (98, 99), thus 
questioning the function of CD46 as an essential pilus receptor for pathogenic 
Neisseriae. 
 
D. Opacity (Opa) proteins 
The Opa (opacity) proteins are a family of antigenic- and phase-variable 
integral outer membrane proteins, found in the pathogenic Neisseria. According 
to the predicted protein structure, the proteins are comprised of eight membrane 
spanning domains with four surface- exposed loops (120). Opa proteins were 
originally identified by their ability to confer opacity and color changes to 
colonies of N. gonorrhoeae grown on translucent agar when they are viewed 
under diffused light with a stereomicroscope (66). It was demonstrated that the 
intravaginal inoculation of female mice with gonococci of an Opa
−
 phenotype 
results in their conversion to an Opa
+
 phenotype; these proteins are important for 
gonococcal survival and pathogenesis (91, 104). 
Eleven opa genes are possessed by Neisseria gonorrhoeae, while Neisseria 
meningitidis only has four opa genes. The Opa proteins are subject to high 
frequency phase variation and express up to 0-4 Opas at a time (9, 13). The 
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changes in the number of poly CTCTT coding repeats (located in the signal-
encoding region of the genes) leads to phase variation. Slipped-strand mispairing 
affects changes in the CTCTT repeats, resulting in translational frame shifts, so 
that multiple or one Opas are expressed at a time (91, 143). 
The Opas mediate a tight secondary attachment with the epithelial cells of the 
urogenital mucosa; they also have two host cell receptors: heparin-sulfate 
proteoglycans (HSPG) and carcinoembryonic antigen-like molecules 
(CEACAMS) (44, 60, 75, 223). The interaction of Opa proteins with CEACAM, 
on host neutrophils leads to down regulation or death of host immune cells (44). 
When Opas interact with phagocytes, they trigger signaling cascade such that Src-
family tyrosine kinases and small G-protein Rac1 are activated, thereby 
facilitating the intracellular accommodation and survival of gonococci in 
professional phagocytes (80, 195). 
 
E. IgA Protease 
IgA1 is the most abundant IgA subtype on human mucosal surfaces and is 
generated by mucosal lymphocytes. All pathogenic Neisseria secrete one of two 
closely related types of IgA1 proteases. The secreted enzyme cleaves human 
IgA1, but not IgA2. The IgA1 proteases are useful in cleaving IgA1 molecules to 
yield intact Fc and F(ab) fragments (140). Cleavage of intact IgA1 results in the 
loss of Fc-mediated secondary effector functions, such as inhibition of adherence 
and the retention of antigen-binding activity by the F(ab) fragments. It has been 
hypothesized that F(ab) fragments may simultaneously block the binding of intact 
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(functional) antibodies of IgA or other isotypes to bacterial epitopes and 
thereby inhibit complement activation and bacteriolysis (83). 
The potential role(s) of the IgA1 proteases may extend beyond cleavage of 
IgA1. Human LAMP1 (hLAMP1), a major integral membrane glycoprotein of 
lysosomes, can be cleaved by IgA1 protease (4, 79) and thereby help in 
gonococcal transepithelial trafficking (88, 115) and inhibition of TNF-α-
mediated apoptosis (6). Since IgA1 is thought to be the predominant antibody 
subclass protecting mucosal tissues against microorganisms, the cleavage of 
IgA1 by the neisserial enzyme might impair the local mucosal immune 
function (212). 
 
F. Reduction Modifiable Protein (Rmp) 
Reduction modifiable protein is a surface exposed outer membrane protein 
expressed by Neisseria species. This protein shows homology to OmpA of E. 
coli and after reduction and SDS-PAGE analysis the protein shows a shift in 
molecular weight, thereby earning its name (74).  It is unique among the 
major outer membrane antigens of the gonococcus, as it differs from the other 
surface-exposed gonococcal outer membrane proteins by its high degree of 
intrastrain and interstrain homology in molecular weight, structure, and 
immunology (119). Rmp appears to be stably associated with porin and LOS, 
even after being subjected to harsh dissociating conditions (86, 125). It was 
shown that antibodies produced against Rmp inhibit the binding by anti-porin 
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and anti-LOS antibodies, thus reducing bactericidal activity by the serum. 
Rmp may act to promote infection in the host by Neisseria (15). 
 
V. Iron availability in the human host 
Iron is an essential element for most organisms, including bacteria, with the 
exception of the bacterial genera Lactobacillus and Borrelia. It is contained in many 
redox enzymes of the intermediary metabolism and in membrane-bound electron 
transport chains of respiratory systems and photosynthesis. Iron is perfectly suited for 
its role in electron transport chains because of the wide range of Fe
2+
/Fe
3+
 redox 
potentials from −300 to +700 mV, depending on the iron ligands and the protein 
environment (25).  
However, despite its abundance on earth, and the micromolar concentrations 
required for cell growth, it is biologically unavailable in most environments. In 
aerobic inorganic environments, iron is present essentially in the oxidized ferric form 
Fe
3+
, which aggregates into insoluble oxy-hydroxide polymers. When reduced, the 
Fe
2+
 activates the Fenton reaction (Fe
2+
 + H2O2 → Fe
3+
 + OH
−
 + OH), leading to the 
partial reduction of oxygen into hydroxyl radicals that are deleterious for most 
macromolecules as they damage DNA, lipids, and proteins (222). Protection against 
iron is achieved by iron sequestration into carrier proteins. To avoid Fenton 
chemistry, iron must be carefully chaperoned through the body by human serum 
transferrin (hTf) where it is solubilized and stabilized as Fe
3+
 or stored in ferritin. The 
various iron carrier proteins in the host are: 
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A. Transferrin 
Transferrin (Tf), an iron transport protein, is found in serum, lymph and 
seminal fluids. It has an approximate molecular weight of 80kDa and is a 
bilobed glycoprotein (225, 134). Each lobe of Tf (N- and C- lobe) is capable 
of binding of two atoms of iron, and each lobe contains two domains. X-ray 
crystal structures reveal that the two similarly folded globular lobes are 
divided into two domains by a large cleft that carries the iron binding site 
(225). Tf is present in substantial levels (25–44 μM) in serum, but is only a 
minor component (0.2–1.3 μM) of mucosal secretions (185). In serum, the 
iron saturation of Tf is usually 30%, with iron primarily occupying the N-lobe, 
and the level of iron saturation can be reduced substantially during infection 
(239). Tf has both an iron transport function and a protective function against 
iron toxicity. Iron-bearing hTF in the blood binds tightly to the 
specific transferrin receptor (TFR). After undergoing endocytosis, 
acidification of the endosome initiates the release of Fe
(3+)
  . Iron-free hTF is 
recycled back to the cell surface and it is released to sequester more iron 
(117). 
B. Lactoferrin 
Lactoferrin (Lf) is a non-haem iron-binding protein that is found in 
mucosal secretions, including tears, saliva, vaginal fluids, semen and released 
by leucocytes at sites of inflammation (73). Lf exhibits an extremely high 
affinity constant for the FeIII ion (Ka -10
20
 M
−1
) compared to affinity constant 
for FeII (10
3
 M
−1
). Lf is structurally very similar to Tf and is an 80 kDa 
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glycosylated protein, but differs in that it is capable of retaining iron under 
acidic conditions (pH < 6) (225). Lf is present at very low levels in serum 
(3.8–8.8 nM) but is a significant component of mucosal secretions (6–13 μM) 
(185). Lf plays a key role in maintaining cellular iron levels in the body and 
in Fe
3+
 homeostasis. The antibacterial activity of Lf is due to its ability to take 
up the Fe
3+
 ion, limiting use of this nutrient by bacteria at the infection site 
and inhibiting the growth of these microorganisms as well as the expression of 
their virulence factors. Lactoferrin is a modulator of the innate and acquired 
immune systems. Depending on the immune status of an individual, Lf can 
have anti-inflammatory properties that down regulate the immune response 
and prevent septic shock and damage to tissues (73). 
C. Ferritin 
In the human host, ferritin is the major iron storage protein. Ferritins 
constitute a broad superfamily of spherical, shell-like iron-storage proteins 
and are composed of 24 protein subunits that form a hollow sphere. The 
majority of iron in the body is stored intracellularly in ferritin (up to 4,500 
Fe
3+
 atoms per ferritin molecule). Ferritin protects eukaryotic cells from the 
toxic effects of iron accumulation. It also stores iron, making it available in 
case of iron shortage.  Following cell lysis, ferritins are also found in plasma 
(169, 225). 
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D. Heme binding proteins 
Heme bound to hemoproteins constitutes the major iron reservoir in 
mammalian hosts and is the preferred iron source of bacterial pathogens. 
Hemoglobin is located in red blood cells, where it functions as the oxygen 
transporter. It is a tetramer with two α- and two β-chains. Each subunit binds a 
heme molecule. Haptoglobin is a serum tetrameric glycoprotein. In serum, 
haptoglobin binds the hemoglobin, released by hemolysis, with a high affinity. 
The haptoglobin-hemoglobin complex is an iron source for several bacteria 
like Neisseria meningitidis, and Haemophilus influenzae (225). Heme, the iron 
protoporphyrin IX molecule, is a prosthetic group for many enzymes. It is a 
protoporphyrin source for several species, including Enterococcus 
faecalis, Lactococcus lactis, and Haemophilus influenzae (225). 
VI. Iron acquisition Systems 
 
Iron acquisition is accomplished by microorganisms via two general mechanisms: 
iron acquisition by cognate receptors using low molecular weight iron chelators 
termed siderophores and receptor-mediated iron acquisition from host proteins. The 
first mechanism relies on siderophores, synthesized and released by bacteria into the 
extracellular medium. The second involves direct contact between the bacterium and 
the exogenous iron sources using specific host-iron binding protein receptors.  The 
main difference between these two mechanisms is that siderophores and heme can be 
taken up by the bacterial cell as intact molecules whereas iron must be extracted from 
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host carrier proteins such as transferrin or lactoferrin prior to being transported into 
the bacterial cell. 
The uptake of iron from transferrin, lactoferrin, hemoglobin, and siderophores has 
been identified in both Gram-negative and Gram-positive bacteria.  Transferrin, 
lactoferrin, hemoglobin, and most ferric-siderophore complexes exceed the molecular 
weight cut off of porins and thus require specific outer membrane receptors for 
uptake into the periplasmic space. These high-affinity outer membrane receptors 
share some common characteristics. They have a low level of primary sequence 
homology that is most pronounced in their amino termini, and their transport function 
depends on a complex of three proteins localized in the cytoplasmic membrane 
(TonB, ExbB, and ExbD) that we call the TonB complex (225). Gram-negative 
pathogens use a variety of transporters to access the host iron sources. For example in 
V. cholerae, iron bound to haem/hemoglobin is actively transported into the cell via 
ligand-specific outer membrane receptors (128, 203), in E. coli iron bound to organic 
acids like citrate is utilized by FecA transporter (24), Haemophilus influenzae and H. 
haemolyticus acquire iron bound to human transferrin through specific transporters 
(138). 
Siderophores (from the Greek: “iron carriers”) are defined as relatively low 
molecular weight, ferric ion specific chelating agents elaborated by bacteria and fungi 
growing under low iron stress. The role of these compounds is to scavenge iron from 
the environment and to make the mineral available to the microbial cell (148). More 
than 500 different siderophores, mostly produced by Gram-positive and Gram-
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negative bacteria, have been described. Despite this great variety, most have a peptide 
backbone with several nonprotein amino acid analogs. Based on their iron ligation 
groups, siderophores have been tentatively classified into three main chemical types: 
hydroxamates (e.g. aerobactin), catecholates (e.g. enterobactin), and hydroxyacids 
(e.g., pyochelin) (169, 225). 
A common pattern of bacterial siderophore transport systems in Gram-negative 
bacteria has been identified. An outer membrane transporter binds the Fe
3+
-
siderophore complex. The barrel of the transporter, consisting of 22 β-strands and an 
inside plug, binds the iron complex in the barrel entrance. Internalization of this 
complex is an energy-dependent process, with the TonB-ExbB-ExbD complex 
providing the energy (25). Many bacteria are able to utilize siderophores produced by 
other organisms, so-called xenosiderophores. For example, E. coli K-12 can utilize 
the fungal siderophores ferrichrome and coprogen and citrate in addition to it own 
siderophore enterobactin.  In E. coli multiple receptors have been identified and their 
crystal structures have been solved. Some of them are FepA (enterobactin) and FhuA 
(ferrichrome) (23, 39). 
 
VII. TonB-Dependent Transporters 
In Gram-negative bacteria, transport of siderophores into the periplasm is 
mediated by TonB-dependent receptors (68, 225). TonB-dependent transporters have 
also been well characterized in iron acquisition pathways mediated by host-iron 
binding proteins (52, 188, 194). 
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TonB-dependent transporters share a common topology. They all are composed of 
two characteristic domains: (i) a C-terminal beta-barrel (spanning the outer 
membrane), comprised of 22 amphipathic, antiparallel β-strands, and a globular plug 
domain, located at the N-terminal position and is folded up inside the barrel (55, 68, 
107). The plug domain of the outer membrane receptor contains a conserved, 7 amino 
acid sequence: the TonB-box. The TonB box is found at the N terminus of the plug 
domain and in some structures protrudes into the periplasm. In other structures, the 
TonB box is tucked up into the plug domain within the barrel or is disordered and not 
visible in the structures (22, 30, 225). This conserved region adopts a variety of 
conformations, ranging from folded to unfolded, and is believed to participate in 
interactions between TonB and the TonB-dependent transporter and is the primary 
signature of TonB dependence  (152, 162).  
The energy that is required for the active transport of iron-laden substrates 
through the TonB-dependent outer membrane receptor is provided by 
the TonB/ExbB/ExbD complex, which is located in the cytoplasmic membrane. The 
TonB protein complex harnesses energy generated by the proton motive force in the 
inner membrane, and then transduces it to the outer membrane (100, 107, 161). The 
binding of iron-bound ligand to the extracellular pockets of outer membrane receptors 
causes a TonB-independent allosteric transition that is propagated through the outer 
membrane. This results in formation of a transmembrane channel within the receptor, 
through which the ligand permeates into the periplasm. Upon arrival in the periplasm, 
siderophores are rapidly bound by specific periplasmic binding proteins, and shuttled 
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to distinct ABC transporters embedded within the cytoplasmic membrane for 
transport into the cytoplasm (68, 106, 135).  
TonB-dependent uptake systems permit bacterial growth in a wide range of iron-
limited environments. These systems are also considered targets for novel antibiotics, 
because they contribute to the specific permeability of the Gram-negative cell 
envelope (135). 
VIII. Iron Acquisition in Pathogenic Neisseria 
Two general mechanisms of iron acquisition in bacteria have been described: 
siderophore-mediated iron acquisition by cognate receptors and receptor-mediated 
iron acquisition from host iron-binding proteins. Many enteric bacteria use 
siderophore-mediated iron uptake.  In Neisseria, however, there is no known 
production of siderophores (185, 231). Still enterobactin and aerobactin have been 
shown to support the growth of pathogenic Neisseria. To overcome the iron limited 
host environment, these highly adapted obligate human pathogens can efficiently 
utilize multiple host iron (Fe) sources, allowing replication on mucosal surfaces, in 
the bloodstream, and intracellularly. Pathogenic Neisseria express multiple high-
affinity iron transporters to acquire iron from transferrin, lactoferrin and hemoglobin 
(113, 132, 187). Although these receptors may vary in complexity and composition, 
all three systems are structurally similar in consisting of an outer membrane TonB-
dependent transporter and an accessory lipoprotein.  
The transferrin binding proteins and the receptor complex are discussed in detail 
in the next chapter. The lactoferrin iron utilization system is made up of lactoferrin 
26 
 
binding proteins A and B (LbpA and LbpB). LbpA is the TonB-dependent transporter 
and essential for iron internalization, LbpB is a lipoprotein and not required for 
lactoferrin iron utilization. The HpuAB receptor is responsible for utilization of iron 
from hemoglobin and hemoglobin-haptoglobin.   The receptor is made up of HpuB 
and HpuA; both of which are required for iron internalization. HpuB is an 85 kDa 
TonB-dependent outer membrane transporters and HpuA, is a 34.8 kDa lipoprotein 
(156). To utilize iron bound to hemoglobin, only  Neisseria meningitidis expresses the 
HmbR hemoglobin receptor. HmbR is an iron-regulated 89.5 kDa outer membrane 
protein that mediates iron acquisition from hemoglobin but not from hemoglobin-
haptoglobin (204).  
IX. Gonococcal Transferrin Receptor 
The neisserial transferrin–iron import system consists of two dissimilar transferrin 
binding proteins, TbpA and TbpB. The neisserial receptor involved in iron acquisition 
from human Tf is preferentially expressed under conditions of iron deprivation (49, 
189). The tbpA and tbpB genes are arranged in a bicistronic operon, with the tbpB 
gene located upstream of tbpA (52, 112, 178). The two genes are separated by an 86 
base pair region, potentially capable of forming a stem-loop structure in the mRNA. 
Using lacZ fusion and RT-PCR approaches, under iron-stressed conditions, it was 
shown that there are twice as many tbpB-specific transcripts as tbpA-specific 
transcripts, yielding an apparent tbpB/tbpA ratios of approximately 2:1 (178). This 
implies that the secondary structure of the intergenic region might function in 
maintaining transcript stoichiometry (178). The tbpAB promoter contains a Fur 
binding site and is under the control of the Fur protein. Fur (ferric uptake regulator) is 
27 
 
a global regulator, which in the presence of iron represses gene transcription. This 
regulatory mechanism leads to preferential expression of Tbps under iron-limited 
conditions.  
TbpA is an integral outer membrane protein that provides the pore through which 
iron is transported across the outer membrane of gonococci (52). Recently, the crystal 
structures of components of the meningococcal transferrin–iron uptake system were 
reported (31, 151). TbpA is conserved in pathogenic Neisseria and shares similarity 
with other TonB-dependent outer membrane proteins (166, 171). Similar to the 
solved crystal structures of many such transporters, the TbpA structure is 
characterized by  a C-terminal  beta-barrel domain comprised of 22 amphipathic beta-
strands and an N-terminal  globular plug domain that is folded up inside the beta- 
barrel (150). The TonB-dependent transporter is energized by TonB and ExbB and 
ExbD (106, 150). Gonococcal mutants not expressing TbpA were capable of binding 
some transferrin but incapable of growth on transferrin as the sole iron source (48, 
52),  making TbpA essential for transferrin-iron uptake. 
The second member of the transferrin-iron uptake system is TbpB, which is a 
lipid-anchored protein, presented on the outer leaflet of the outer membrane. TbpB is 
capable of binding transferrin (1, 112). TbpB is not essential for iron acquisition but 
makes the process more efficient (1). TbpB is capable of discriminating between apo- 
and holo-transferrin and preferentially binds holo-transferrin. Gonococcal TbpB 
mutants showed decreased iron-uptake from transferrin but grew with transferrin as a 
source of iron (1). TbpB has the ability to affect rapid association and dissociation of  
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transferrin on the cell surface, thereby allowing optimum ligand to be delivered to 
TbpA and once the iron has been removed from the ligand, to aid in the release of 
apo-Tf (63). TbpB may also participate in deferrating transferrin (191) and work in 
concert with TbpA to make the transferrin-iron acquisition process more efficient. 
In the gonococcal iron internalization process (figure 1), transferrin binds to TbpA 
and TbpB on the outer membrane. The cytoplasmic membrane TonB-ExbB-ExbA 
protein complex interacts with the TonB box sequence in the TbpA plug domain. Iron 
is stripped from transferrin, in an energy dependent process, and translocated through 
the TbpA barrel into the cell periplasm. Iron is then bound to apo-FbpA, a 
periplasmic iron binding protein, which shuttles the iron across the periplasm to the 
cytoplasmic membrane. The inner membrane FbpB-FbpC permeases transport iron to 
the cytoplasm in an ATP dependent manner (figure 1). 
Several studies have demonstrated that TbpA and TbpB function together for 
extracting iron form holo-transferrin. Evidence of complex formation between TbpA 
and TbpB has been described in the pathogenic Neisseria. Using radiolabelled 
transferrin binding assays, it was demonstrated in Neisseria meningitidis, that TbpA 
and TbpB did form a complex (160). Studies utilizing photon correlation 
spectroscopy (19) to analyze complex formation in N. meningitidis have concluded 
that affinity purified TbpA and TbpB physically associate with each other. Results of 
transferrin-binding affinity purification, and protease accessibility experiments  
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Figure 1: Schematic model of the transferrin iron acquisition system in Neisseria 
gonorrhoeae. The transferrin iron acquisition system is composed of two transferrin binding 
proteins, the surface exposed TbpA and TbpB. TbpA is a TonB-dependent transporter, serving as 
a channel for iron internalization. TbpB is an accessory protein, tethered on the outer leaflet of 
the outer membrane through its lipid moiety. Ferrated transferrin binds to the Tbps and iron is 
removed and internalized in an energy dependent manner, the energy is supplied by the TonB-
ExbD-ExbB complex by TbpA-TonB interaction. Iron is internalized and in the periplasm binds 
the periplasmic binding protein, FbpA; it is then shuttled across the periplasm to the FbpB-FbpC 
permease complex in the inner membrane, which then brings the iron into the cytoplasm in an 
ATP-dependent step. 
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showed that both TbpA and TbpB function together in the wild type gonococcal 
strain and both of the  Tbps together show  binding conformations that are distinct 
than those expressed by either of the Tbp alone in the mutant. The protease exposure 
of TbpB was affected by the energization of TbpA, consistent with an interaction 
between these proteins (48, 54). Co-immunoprecipitation assays have suggested that 
TbpA and TbpB may interact with one another on the cell surface. TbpA-specific 
antibodies were able to co-immunoprecipitate TbpB from outer membrane fractions, 
even in the absence of transferrin (96), suggesting that even in the absence of 
transferrin the two proteins associate with each other. Recent reports of complex 
crystal structures and electron microscopy analysis, have proposed the Tbps 
functioning together to bind and extract iron from transferrin (150).  
 
X. Gonococcal Vaccine Development 
The new superbug Neisseria gonorrhoeae has maintained resistance to previously 
described antibiotics and developed resistance to ceftriaxone, the last remaining 
option for treating gonorrhea (214). The rise in untreatable gonorrhea poses an 
exceedingly serious public health problem. No vaccine to protect against gonorrhea is 
available. Progress in developing a vaccine has largely been stymied due to antigenic 
variation displayed by the organism, coupled with the host's inability to generate a 
protective immune response (84). Gonococci are well-adapted pathogens since many 
of its surface antigens like pilin and opacity proteins undergo high frequency phase or 
antigenic variation, making the surface of the gonococcus difficult to target for a 
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protective immune response. Much vaccine work has focused on surface exposed 
antigens that clustered in the outer membrane, like porins, pili, and Rmp. A trial of a 
purified gonococcal pilus vaccine composed of a single pilus type was tested in male 
volunteers. This gonococcal pilus vaccine composed of a single pilus type failed to 
protect men against gonococcal urethritis (18) possibly due to antigenic variation. 
Porin was evaluated as a vaccine candidate as it does not undergo phase variation, is a 
major outer membrane protein and is important for invasion. The results were 
unsuccessful as sialylated LOS partially masks adjacent porins and reduces antibody 
binding to porins. Rmp elicits blocking antibodies that subverts anti-porin antibodies 
(175, 232, 241). 
Utilizing proteins involved in iron acquisition as vaccine candidates seems 
rational as iron is critical for Neisseria survival. The Tbps are attractive vaccine 
candidates because they are not subject to high frequency phase or antigenic 
variation, are surface exposed, and are expressed by all clinical strains (132). In a 
study with human male volunteers, intraurethral inoculation with Tbp
−
 mutant strain 
was incapable of initiating urethritis, indicating that Tbps are necessary for 
establishment of infection in human male infection model (53). Analysis of intranasal 
immunization with recombinant Tbp proteins conjugated to the cholera toxin B 
subunit showed that these antigens elicited antibody responses in the serum and 
genital tract of female mice (164). The results reported strengthen the proposal to 
include components of the neisserial transferrin receptor in vaccine candidates. 
 
33 
 
 
XI. Research Objectives 
A number of reports have together contributed to the study of iron utilization from 
human transferrin in the Neisseria species.  Studies, in the past, have attempted to 
decipher the gonococcal transferrin receptor  and provided several indirect lines of 
evidence demonstrating complex formation between the Tbps. Previous studies in our 
lab have generated hemagglutinin (HA) epitope insertion mutants in TbpA and TbpB, 
to investigate the surface-exposed regions in the Tbps. The Hemagglutinin (HA) 
epitope tag was inserted in a number of conserved and variable regions of TbpA and 
TbpB, with the intention to study structure-function relationships between the Tbps. 
The overall goal of the proposed studies here was to probe the structure-function 
relationships in both the Tbps in order to determine the important domains for 
interaction between the two Tbps, thereby yielding important information for a 
rational design of a vaccine against gonococcal infections. First we examined the iron 
binding properties of the conserved EIEYE sequence in the TbpA plug domain, with 
the intention of extending our knowledge about transferrin-iron internalization 
through TbpA. Secondly, we utilized photoactivable cross-linkers to assess the effect 
of TbpA on TbpB in the gonococci and studied it in presence of ligand and TonB 
derived energy. We employed insertion mutants, in which TbpA contained the 
hemagglutinin (HA) epitope tag, to probe for impact of TbpA on TbpB. And lastly, 
we sought to characterize the importance of TbpB regions in the functional and 
structural relationships of TbpB . 
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This study will help to elucidate additional characteristics of the interaction 
between the gonococcal Tbps in vivo. By looking at the structural and functional 
properties of the two members of the gonococcal transferrin receptor, we will have a 
better understanding of mechanisms of iron acquisition through the Tbps. The Tbps 
have a potential to be vaccine candidates and knowledge derived from our study 
might be important for the rational design of a vaccine comprised of one or both of 
the transferrin binding proteins. 
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CHAPTER 2: Materials and Methods 
I. Bacterial Growth Conditions 
A. Strains and media 
The N. gonorrhoeae strains used in this study are listed in Table 3. Gonococci were 
routinely maintained on GC medium base (Difco) containing Kellogg’s supplement 1 (94) 
and 12 μM ferric nitrate (Supplement II) at 37oC in a 5% CO2 atmosphere. For growth under 
iron-stressed conditions, which allows for  maximal expression of transferrin binding 
proteins, liquid cultures of gonococcal strains were grown in acid-washed glassware 
containing chemically defined media (CDM) (137, 230). The CDM was rendered iron free by 
treatment with Chelex 100 (BioRad). Plasmids were propagated in TOP10 (Invitrogen) E.coli 
strains, grown at 37
o
C in Luria-Betani broth (7,8), supplemented with  50μg/ml of kanamycin 
(Sigma). 
B. Bacterial growth in photoreactive CDM Media 
Photoreactive amino acids L-Photo-Leucine and L-Photo-Methionine (Thermo Scientific) 
were used as cross-linking reagents. To the liquid chelexed defined medium (CDM)     
photoreactive amino acids were added at a final concentration of 0.7 mM photo-leucine and 
0.1mM photo-methionine. Bacterial cultures were grown in a shaking incubator at 37°C, in 
an atmosphere supplemented with 5% CO2.  After four hours of growth, cultures were UV 
irradiated and standardized to culture density.  
 
 
36 
 
 
 
Table 3: Neisseria gonorrhoeae strains 
 
     Strain    Phenotype (genotype)          Reference/Source 
Neisseria gonorrhoeae strains 
 
 
FA19   Wild type (TbpA
+ 
TbpB
+
)      (131) 
FA6747  TbpA
− 
(tbpA::mTn3cm)       (52) 
FA6905   TbpB
− (ΔtbpB)         (48) 
MCV515  L9HA (750) TbpA Lbp
- 
(tbpA HA lbpB::Ω)    (238) 
MCV519  L11HA (843) ΔAla847 TbpA Lbp
-
 (tbpA HA lbpB::Ω)  (238) 
MCV523  β16HA (713) TbpA Lbp
- 
(tbpA HA lbpB::Ω)    (238) 
MCV527  L2HA (229) TbpA Lbp
- 
(tbpA HA lbpB::Ω)    (238) 
MCV260  TbpAE120AY121AE122ATbpB
+
     (153) 
MCV814  HA4 (293) TbpB Lbp
- 
(tbpA HA lbpB::Ω)    (62) 
MCV822  HA8 (607) TbpB Lbp
- 
(tbpA HA lbpB::Ω)    (62) 
MCV839  TbpB LSAC (lbpB::Ω)          (157) 
MCV843  TbpB Δgly (lbpB::Ω)                (157) 
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II. Recombinant Protein Expression and Purification  
A. Recombinant tbpA (WT) and tbpA (EYE120AAA) plug protein expression 
Starter cultures of E. coli expression strain BL21 (DE3) (containing the wildtype 
and mutagenized tbpA plug-encoding domains) were grown in LB media containing 
100 μg/ml Ampicillin, for approximately 4 hours at 37oC. After growth, the starter 
cultures were centrifuged at 5000 x g for ten minutes and the bacterial cell pellet was 
resuspended into fresh LB media with 100 μg/ml ampicillin. The freshly resuspended 
starter cultures were then used to inoculate 1L of LB broth with 100 μg/ml ampicillin. 
The cultures were incubated at 37
o
C with a constant shaking at 225 rpm. When the 
cultures reached an O.D. between 0.4-0.8, protein expression was induced with the 
addition of 1mM IPTG (isopropyl-B-D-thiogalactopyranoside) (Sigma). The cultures 
were allowed to induce for four hours at 37
o
C with a constant shaking at 225 rpm. 
After the induction, the cultures were allowed to centrifuge at 8000 x g for 25 
minutes. The supernatant was discarded and the pellets were resuspended in sterile 
1X PBS (pH 7.2) and centrifugation was performed at 9000 rpm for 20 minutes. The 
supernatants were removed and the bacterial pellets were dried and stored at -20
o
C 
overnight.  
B.  tbpA (WT) and tbpA (EYE120AAA) plug protein purification 
The bacterial pellets were thawed on ice and resuspended in Lysis buffer (50mM 
NaH2PO4, 300 mM NaCl, 10mM Imidazole, at pH 8.0). Lysozyme and His-tagged 
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Protease Cocktail inhibitor (Biorad) was added at a concentration of 1mg/ml and 
1ml/20gms respectively. The cell pellet was resuspended and allowed to incubate for 
30 minutes on ice. The cellular mixture was sonicated and the lysate separated from 
the debris by centrifugation at 10000 x g for 30 minutes at 4
o
C. The supernatant was 
then incubated with 50% Ni-NTA slurry (Qiagen) overnight at 4
o
C. Then, the next 
day the mixture (containing the Ni-NTA resin) was added to a column and the first 
flow-through fraction was collected in a fresh tube. The resin in the column was 
washed twice with 5ml of Wash Buffer (50mM NaH2PO4, 300 mM NaCl, 20mM 
Imidazole, at pH 8.0) and collected in two separate tubes. The recombinant proteins 
were eluted from the resin-column with the elution buffer (50mM NaH2PO4, 300 mM 
NaCl, 250mM Imidazole, at pH 8.0). The purified proteins were dialyzed against 
2000 fold 1X PBS (pH 7.2). 
C. SDS-PAGE, protein transfer and detection of purified protein 
The various purified protein fractions were solubilized in 2X Laemmli 
solubilizing buffer (109). The samples were then heated at 100
o
C for 2 minutes after 
the addition of 5% β-mercaptoethanol. After allowing the heated samples to cool, 
they were loaded on to a 15% gel and subjected to sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) (109). The separated proteins were 
then transferred to a nitrocellulose membrane at 28mAmp for 16 hours in 20mM Tris 
base, 150mM glycine and 20% methanol (211). 
For detection of His-tagged purified recombinant proteins, the nitrocellulose 
membrane was blocked with 5% skim milk in low-salt Tris-buffered saline (LS-TBS). 
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Blots were probed with anti-His-tag monoclonal antibodies (Calbiochem) at a dilution 
of 1:1000, as primary antibody the blots were then washed with LS-TBS containing 
Tween-20 and then probed with goat-anti-mouse IgG AP (BioRad) at a 1:5000 
dilution NBT/BCIP (Sigma) was used for developing and visualizing the protein 
bands on the membranes. 
D. Coomassie blue staining  
To detect purified protein bands, the SDS-PAGE gels (with the separated 
proteins) were stained with Coomassie blue (0.25% Coomassie R-250, 50% 
methanol, 10% glacial acetic acid) the gels were left in the blue stain solution 
overnight at room temperature. The gels were destained in 20% methanol and 5% 
acetic acid at room temperature till the background was destained and the protein 
bands visualized. 
 
III. Immunoblotting and Detection 
A. Preparation of whole cell lysates 
To evaluate the expression of Tbps, gonococcal cultures were grown in CDM 
under iron-depleted conditions. After four hours of growth, cultures were 
standardized to constant cell density. Samples were centrifuged at 14000rpm for 
10mins. Cell pellets consisting of approximately 1 x 10
12
 cfu were resuspended in 100 
μl of 2X Laemmli solubilizing buffer (109).   
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B. SDS-PAGE and protein transfer 
Prior to gel analysis 2µl of benzonase nuclease (Sigma) was added to the whole 
cell lysates and incubated for 10 minutes at room temperature, to decrease the 
viscosity of the prepared cellular lysates. After the incubation 5% β-
mercaptoethanol (Sigma) was added to the whole cell lysates and they were 
heated at 95°C for 2 minutes. Samples were allowed to cool down to room 
temperature and centrifuged for 30 seconds at 14000 rpm. Samples were analyzed 
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on a 
7.5% polyacrylamide gel using a Mini-Protean III apparatus (Biorad).  Separated 
proteins on the gels were transferred to nitrocellulose membrane (Schleicher and 
Schull) in 20mM Tris base, 150mM glycine and 20% methanol in a submerged 
transfer apparatus (Biorad) at constant current of 28mAmp for 16 hours. 
Before western blotting, to confirm equal protein loading in each lane, the 
nitrocellulose membranes were stained with Ponceau S solution (0.1% w/v 
Ponceau S, 5% acetic acid) for 10-12 minutes and excess stain rinsed with 
distilled water. 
 
i) TbpA detection 
To detect TbpA nitrocellulose membranes were blocked with 5% BSA in 
high salt Tris-buffered saline (HS-TBS: 20mM Tris base, 500mM NaCl). The 
blocked membrane was probed with 1:1000 dilution of primary anti-TbpA 
polyclonal antibodies for 1 hour as described (48). The primary antibody was 
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detected with a goat anti-rabbit antibody conjugated to alkaline phosphatase 
(Biorad) at a dilution of 1:5000 for 1 hour. The membrane was washed in HS-
TBA with 0.05% Tween-20 (Sigma). Blots were developed using NBT/BCIP 
(Sigma) in buffer containing 100 mM Tris (pH 9.5), 50 mM MgCl2, and 100 mM 
NaCl. 
ii) TbpB detection (using anti-TbpB antibodies) 
To detect TbpB, the nitrocellulose membranes were blocked with low-salt 
Trus buffered saline (LS-TBS) containing 5% non-fat dry skim milk (Sigma) for 
an hour. Membranes were probed with 1:1000 diluted primary anti-TbpB 
polyclonal antibodies (163), washed in low salt-TBS and 0.05% Tween-20. Next 
the membranes were probed with goat anti-rabbit alkaline phosphatase conjugated 
(Biorad) secondary antibody at a 1:5000 dilution. The membranes were developed 
with NBT/BCIP developing system.   
iii) TbpB  detection (using transferrin) 
As an alternative method to detect TbpB, we blocked the nitrocellulose 
membranes in 5% non-fat dry skim milk (Sigma) and LS-TBS. The membranes 
were washed with low-salt TBS and 0.05% Tween-20. To detect transferrin-
binding by TbpB, the membranes were probed with horseradish peroxidase 
conjugated Tf (HRP-Tf) at a concentration of 1µg/ml for an hour. HRP was 
detected using Chemiluminesence (ECL) 2 Western Blotting Substrate kit 
(Pierce) (48). Blots were exposed to film to detect TbpB bands bound to 
transferrin.  
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IV. Image J analysis 
The photo-crosslinked samples were analyzed by SDS-PAGE and separated samples 
were transferred to the nitrocellulose membranes. Subsequent to immunoblotting, the 
blot images were captured and the band intensities were quantitated using the Image J 
1.46r (168) imaging system and associated software. 
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CHAPTER 3- DEMONSTRATION OF IRON BINDING BY THE EIEYE SEQUENCE IN 
THE TbpA PLUG OF Neisseria gonorrhoeae 
 
 
 
I. INTRODUCTION 
Neisseria do not produce any known siderophores, however they can utilize 
siderophores produced by other microorganisms (28, 67, 182, 183, 231). In the human host 
iron is sequestered by a variety of soluble iron-carrying glycoproteins or heme compounds. 
Gonococci have evolved mechanisms for obtaining iron from these host iron binding 
proteins. To utilize the bound iron, they express high-affinity receptors to utilize iron bound 
to human transferrin (16, 67, 111, 126, 131), lactoferrin (16, 67, 111, 126, 133) and 
hemoglobin (1,10). The lactoferrin-iron acquisition pathway and the hemoglobin-iron 
acquisition pathway are similar to the transferrin-iron acquisition system; all of them 
comprised of a TonB-dependent transporter and an outer membrane-tethered lipoprotein (10, 
11, 42, 43, 52, 55). Both of these components work together, in a sequential manner, to allow 
the iron-binding glycoproteins to interact with the bacterial cell surface, extract iron from the 
bound form and internalize it across the membranes.  
Gonococci are capable of utilizing human transferrin as a sole source of iron (131), 
through the expression of iron regulated transferrin-iron acquisition system. The transferrin 
iron uptake system consists of Tf- binding protein A (TbpA) and B (TbpB). TbpA is a  
100-kDa integral outer membrane protein, belonging to the family of TonB-dependent 
transporters. Tf-binding protein B is an ~80-kDa co-receptor, attached to the outer membrane 
by a lipid anchor. TbpA is essential for transferrin-iron acquisition but TbpB is not required 
for the same process, instead its presence makes the process more efficient (1).  TbpB serves 
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as an accessory protein in the iron acquisition process, with a capability of differentiating 
between apo- and holo- transferrin (19, 48, 170, 173). Figure 1 depicts the iron acquisition 
process in Neisseria gonorrhoeae (27). The process involves the following steps: 
TbpA/TbpB recognize and bind holo-transferrin, remove apo-transferrin after stripping iron 
(using TonB derived energy), periplasmic FbpA binds iron after it travels through the outer 
membrane, FbpA shuttles the iron across the periplasm to the inner membrane permeases 
FbpB/FbpC, later transporting it to the cytosol (54, 97, 190) 
Recently the crystallization of Neisseria meningitidis TbpA, helped in furthering the 
structural study of the neisserial iron import machinery (151). The crystal structures of 
several of these transporters have been reported by various groups (31, 150, 155). These 
structures are all TonB-dependent transporters, characterized by an N-terminal plug domain 
of ∼ 160 residues (plug domain) folded inside a C-terminal 22-stranded beta-barrel domain 
(β-barrel domain). The plug domain acts as a ligand sensor, by preventing entry of substances 
into the periplasm until the appropriate ligand is bound. 
TbpA is significantly larger than other TonB-dependent transporters, the structure 
consists of 22 transmembrane β-strands, arranged as a barrel, with long surface exposed 
loops, and an  N-terminal plug domain. The TbpA barrel is occluded by the N terminal plug 
domain. The plug domain does not allow the passage of small molecules through the TbpA 
β-barrel. The plug could undergo a conformational change that leads to the ejection of the 
plug domain into the periplasm, thereby forming an entry pathway for the iron cargo directly 
through the outer membrane transporter.   
Previous studies have shown the significance of the TbpA plug domain in the iron 
internalization process (238), however the precise mechanism is unknown. In the plug 
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domain of TbpA the sequence EIEYE (118-122) is highly conserved (figure 2). The triple 
alanine substitution of the Glu120, Tyr121 and Glu122 in a TbpA mutant (EIAAA 118-122) 
showed an 80% reduction in transferrin bound iron utilization (153). This demonstrated the 
importance of the EIEYE sequence in the TbpA plug in transferrin iron utilization. The 
EIEYE motif is well conserved and is suitable for coordinate-covalent bonding to Fe and 
capable of scavenging available iron in the iron deprived host milieu. We hypothesize, that at 
the TbpA/TbpB surface, iron released from transferrin, is bound by the TbpA plug sequence 
(EIEYE) and is transported through β-barrel of TbpA across the outer membrane. In this 
study in vitro and in silico experiments were conducted, utilizing wild-type and triple alanine 
mutated (EIEYE-EIAAA) recombinant TbpA plug samples, and three small peptides (S1, S2, 
S3); each peptide containing the putative iron-coordinating site and specific portions of the 
wild-type TbpA plug domain. 
 
II. RESULTS 
 
To study the protein characteristics of the recombinant TbpA plug proteins, we first 
undertook large scale growth of the E. coli strains expressing the recombinant plug proteins 
(5), and then purified them using the His-tag purification protocol. Protein concentration for 
the purified wild type recombinant TbpA plug protein was 18.18 mg/ml and for the mutated 
recombinant TbpA plug protein was 42.02 mg/ml. After characterizing them for quality and 
protein concentration (figure 3), we examined the secondary structure of the plug (without 
the barrel). First, CD spectra analysis of the wild-type and mutated recombinant TbpA plug 
protein was carried out. The CD spectra for the wild-type and mutated recombinant TbpA  
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Figure 2: Iron coordinating residues in the TbpA plug. In the sequence alignment of TbpA 
plug domains from bacterial pathogens, the first two letters preceding the amino acid sequences 
represent the genus and species of the bacterial pathogen: Ng, Neisseria gonorrhoeae; Nm, 
Neisseria meningitidis; Hi, Haemophilus pleuropneumoniae; Ap, Actinobacillus 
pleuropneumoniae; and Mc, Moraxella catarrhalis. The sequences represent mature TbpA plug 
domains. Dots indicate identical amino acids, letters indicate specific amino acids and dashes 
indicate positions in which gaps were introduced. The inverted triangle represents the site of HA 
insertion and the box indicates the conserved sequence motif selected for site-directed, alanine 
substitution mutagenesis at amino acids 118 (E), 120 (E), 121 (Y), and 122 (E).   
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Figure 3: Characterization of purified wild-type and mutated recombinant TbpA plug 
proteins. Proteins were separated on a SDS-PAGE gel and stained with coomassie blue. The 
contents of the lanes are: lane1- lysozyme, lane 2-protein molecular weight marker, lane 3- wild-
type plug protein, lane 4- mutant plug protein. 
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plug protein was centered around 200nm, in the absence of Fe
3+
. This indicates unfolded 
structures for the wildtype and mutated recombinant plug proteins. This was expected 
because when the proteins are expressed without the β-barrels, there are no stabilizing 
hydrogen bonds formed to induce native secondary structure. This kind of CD spectra has 
been previously reported for the recombinant wildtype FbpA plug and the above observation 
holds true to that study (191). To investigate an interaction between Fe
3+
 and the wildtype 
and mutated recombinant plug protein, and its consequential conformational change in the 
plug, CD spectra studies were carried in presence of Fe
3+
. The interaction between 
recombinant plug domain and its respective cargo has been demonstrated in E. coli (20, 69, 
70, 215). The CD spectra for wildtype and mutated plug protein in presence of Fe
3+
, did not 
show any significant change for either of the protein signals. This observation tells us that no 
apparent conformational change occurs when (or rather if) binding of Fe
3+
 happens at the 
plug domain. 
Fluorescence emission titrations help us to study the binding interactions. In the 
system we are studying, we looked at the binding (if any) between the TbpA plug domain 
and the peptides with Fe
3+
. In the fluorescence emission titrations, the 310nm peak was used 
as a probe.  % quenching (Q%) at 310nm as a function of increasing Fe
3+
,  was measured for 
the wild-type recombinant TbpA plug. The conditional Kd for wildtype recombinant TbpA 
plug is 10
-7
M and the Kd value for S1 (peptide) is 10
-4
M. Upon binding of Fe
3+
, to the 
wildtype recombinant TbpA plug, other amino acids in the TbpA plug could participate to 
stabilize the protein- Fe
3+
 interaction and therefore we probably observed the higher binding 
affinity for the wildtype recombinant TbpA plug compared to the peptide S1. The TbpA 
wildtype recombinant plug contains four tyrosine residues; the EIEYE sequence in the plug, 
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contains one of the tyrosine residues. The S1 peptide under study here contains one tyrosine 
residue. Fluorescence emission properties of the S1peptide and the recombinant TbpA plug 
depends on these tyrosine residues, with the surface exposed tyrosine residues emitting 
fluorescence at 310nm.  
The fluorescence emission experiments aid in studying interaction between Fe
3+
  and 
the TbpA plug/peptide, using 310nm peak as a probe, because the binding between the 
tyrosine and Fe
3+
 leads to decrease in free tyrosine in solution and resultant quenching of the 
310nm band. In fluorescence emission titration spectra for the wildtype recombinant TbpA 
plug, it was seen that the addition of increasing amount of Fe
3+
, led to the quenching of the 
310nm band, indicating a binding event. Similar quenching behavior for the peptide S1was 
observed. The Qmax values at the theoretical endpoint of titration, differ for the wildtype 
recombinant TbpA plug (Qmax value is approx 40%) and the S1 peptide (Qmax value is 100%). 
For the S1 peptide at the end point of titration,  Qmax value of approx 100% indicates that all 
(in this case 1) tyrosine residues are bound to added Fe
3+
. The wildtype recombinant TbpA 
plug has a Qmax value of approx 40%, indicates that all the tyrosine residues (wildtype 
recombinant TbpA plug contains four tyrosine residues) do not participate in Fe
3+
 binding. 
We can speculate that there are two different tyrosine populations, one that participates in 
Fe
3+
 binding (shown by the 310nm band present for quenching), and the other population that 
doesn’t show quenching due to non-binding to Fe3+. The S1 peptide contains the EIEYE 
sequence and shows 100% binding. The wildtype TbpA recombinant plug containing the 
EIEYE sequence, shows a Qmax value of 40%, thereby allowing us to say that EIEYE 
sequence is responsible for binding Fe
3+
  and subsequent quenching of the wildtype TbpA 
recombinant plug. 
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The predicted structures of the wildtype and mutated TbpA plug of Neisseria 
gonorrhoeae were predicted as models, under native conditions through I-TASSER. The top 
of the molecule shows the presence of a loop, called the top hat region, which is formed by 
the presence of a highly conserved sequence, found prior to the EIEYE motif (figure 4). This 
top hat region contains the Ala110 residue, and this residue by HA-insertion tag analysis has 
been shown to lie in the surface exposed region of TbpA (238). This tells us that the top hat 
region is surface exposed and located at the apex of the molecule. The EIEYE motif is in a 
long loop, anchored by beta strands. Prior to binding Fe
3+
, reorganization of atoms takes 
place to maximize binding in the loop; this requires the binding domain to be flexible so as to 
utilize minimum energy. The present model, predicts this sequence to be in a flexible loop 
and allowing ligand binding. The predicted models of the wildtype and mutated TbpA plug 
proteins, show that the EIEYE-EIAAA mutation had the most drastic effect in the surface 
exposed top hat region.  
 
III. DISCUSSION 
In Neisseria gonorrhoeae, iron bound to human transferrin is acquired in the 
following manner: holo transferrin binds to TbpA/TbpB, apo transferrin is recycled from the 
TbpA/TbpB surface after stripping  iron, iron passes through the β-barrel of TbpA, iron binds 
to apo FbpA in the periplasmic side and is transported through the periplasm, it is then 
transferred to the cytoplasm with the help of FbpB/FbpC. TbpA, in this iron acquisition 
process, must help in removing iron from transferrin and then transporting the iron through 
its β-barrel across the outer membrane. A previous study in our lab (154) investigated the 
role of TbpA, specifically the TbpA plug in iron acquisition and iron internalization. In vitro 
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studies have indicated that the TbpA plug domain functions in iron internalization in the 
gonococcal system. Single, double, and triple alanine substitution mutations of the putative 
iron-coordinating residues (EYE- residues 120-122) in the TbpA plug domain resulted in 
mutants that expressed wildtype levels of TbpA on cell surface and bound transferrin with 
wildtype affinity (154). When the double and triple alanine substitution mutants were 
analyzed through transferrin-iron uptake assays they showed a significant defect in 
internalizing iron. The triple alanine substitution mutant was unable to utilize transferrin-
bound iron during transferrin-iron utilization growth assays, in absence of TbpB (154). This 
demonstrates that the TbpA plug domain and residues EYE are critical for transferrin-iron 
acquisition.  
The mutagenesis of the TbpA plug domain could have altered iron binding sites, 
which may be involved in iron removal from transferrin, and subsequently iron binding by 
the plug, and transport across the outer membrane. The substitution mutations in the TbpA 
plug domain could have resulted in indirect impacts within the plug binding domain, 
resulting in the mutated plug’s inability to bind or transport iron. 
TbpA, in addition to being a transferrin receptor, is also an iron transporter. FepA 
(TonB-dependent transporter) of E. coli, in the absence of the β-barrel domain, binds directly 
to its ligand (ferric-enterobactin) (215). This suggests that the plug is important for ligand 
binding and transport. It is possible that in addition to residues 120-122 of the plug domain, 
there could be the involvement of other residues/domain in the transferrin-mediated iron 
acquisition process. Upon TonB interaction with the TbpA plug, the iron binding site or sites 
unravel and facilitate traversal of iron through the outer membrane. This could mean that iron 
is coordinated at multiple sites, with movement of iron from one coordination site to the next 
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one till it reaches FbpA in the periplasm. FbpA has one iron coordination site. In vitro 
recombinant iron binding data shows that TbpA plug domain binds more iron than FbpA, 
suggesting that the TbpA plug could bind iron at more than one site. 
In this study we set out to test our hypothesis that iron that is released from transferrin 
at the TbpA surface binds with the plug sequence (EIEYE) and is transported through β-
barrel. We utilized wildtype and triple alanine mutated recombinant TbpA plugs to conduct 
in vitro experiments to prove the hypothesis. We started the study with large scale expression 
and purification of wildtype and triple alanine substituted recombinant TbpA plug proteins 
from E. coli expression strains. Three small peptides (S1,S2,S3) containing the EIEYE 
sequence of the wildtype  TbpA plug were also synthesized to be used in this study. CD 
spectroscopy was used to study the secondary structures of the wildtype and mutant 
recombinant plug proteins; the possible change in secondary structure (if any at all) due to 
addition of Fe
3+
 was also studied. The CD data suggested an unfolded structure for both the 
wildtype and recombinant plug proteins which could be because the plugs were expressed 
without the β-barrel and did not fold into their native conformation. Fluorescence emission 
titrations were performed to determine the conditional binding constants of the wildtype and 
mutant recombinant TbpA plug proteins. The conditional Kd value for the wildtype 
recombinant TbpA plug is 10
-7
M and for the S1 model peptide is 10
-4
M. Upon the addition of 
Fe
3+
 both the wildtype recombinant TbpA plug and the S1 peptide showed similar quenching 
of the 310nm band, indicating a binding event. No Fe
3+
 binding was detected for the mutated 
(EIEYE-EIAAA) plug (5). This supports our hypothesis that in the TbpA plug domain the 
conserved EIEYE sequence is responsible for binding Fe
3+
. Previous studies by our lab (153) 
have shown that in vivo that there is an 80% reduction in transferrin bound iron utilization in 
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the triple alanine substituted TbpA plug, compared to the wildtype. This observation further 
supports our hypothesis for this study.  
The in-silico modeling data helped in creating a model for the wildtype and mutant 
gonococcal TbpA plug domain.  The EIEYE sequence is a long loop, with β-strands 
anchoring the EIEYE motif. This loop could be flexible in nature due to the need for 
coordination event occurring during the binding of Fe
3+
. The CD spectra and folding studies 
showed that both the wildtype and mutated recombinant plug proteins did not show any 
change in folding characteristics or stability properties in presence of Fe
3+
, this suggests that 
the plug containing the EIEYE sequence must be a flexible loop, which allows for a fluid 
reorganization during the ligand binding and transferring of Fe
3+
.   
Upstream of the EIEYE sequence is another highly conserved region which showed 
conformational differences between the wildtype and mutated TbpA plug structure. This 
region is surface exposed, located at the apex of the molecule and called the top hat region 
(figure 4). In the predicted models of the wildtype and mutated TbpA plug proteins, the 
EIEYE-EIAAA mutation had the most drastic effect in the surface exposed top hat region. A 
previous study from our lab worked with the triple alanine TbpA mutant, to look at the 
ability of this triple mutant to grow on transferrin as the sole source of iron. The study 
showed that the triple alanine mutant bound transferrin with wildtype affinity but showed 
80% reduction in iron uptake and was unable to grow on transferrin, in a TbpB
-
 background. 
These data indicate that the EIEYE motif of the TbpA plug domain is important for 
transferrin-iron internalization and plays an important role in iron acquisition. 
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Figure 4: Schematic representation of the predicted structure of Neisseria gonorrhoeae wild 
type TbpA plug domain. The highlighted EIEYE sequence is postulated to be important for 
iron transport functions through TbpA. The red circle denotes the top hat region. Its importance 
has been discussed in the test. 
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This study is one of the first reports of the expression and isolation of the 
recombinant wildtype TbpA plug. Our studies and results have provided information about 
the iron coordination by the plug domain of TbpA in Neisseria gonorrhoeae. These results 
pave the way for future studies to determine how the tightly-bound iron is released from 
transferrin via the membrane-bound receptor complex, the importance of TbpA/TbpB in the 
stripping of iron from transferrin, how iron is transferred to FbpA through the β-barrel 
architecture and the role of TbpB in this process of transferrin mediated iron acquisition. 
These studies will help us further our understanding to clarify the role(s) that each protein 
plays in the multi-step transferrin-mediated iron transport mechanism in Neisseria 
gonorrhoeae. 
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CHAPTER 4: CONTRIBUTIONS OF TbpA DOMAINS, ENERGY AND LIGAND TO 
INTERACTION BETWEEN GONOCOCCAL TRANSFERRIN BINDING PROTEINS 
 
  
I. INTRODUCTION 
 
In the past, many studies have described indirect lines of evidence pointing towards the 
formation of a gonococcal receptor complex between the transferrin binding proteins. 
Gonococcal mutants expressing only TbpA showed reduced binding of transferrin, decreased 
iron uptake from transferrin, but normal growth on transferrin plates. Mutants expressing 
TbpB and not TbpA bound less transferrin, did not grow on transferrin plates, and did not 
take up iron from transferrin (1). TbpB apparently facilitates binding of transferrin but is not 
essential for acquisition of iron from transferrin; both the transferrin binding proteins need to 
be expressed and work together to accomplish iron utilization from transferrin (1).  
Protease accessibility assays showed that TbpA was more susceptible to proteolytic 
attack in the absence of TbpB. TbpB can be efficiently cleaved by trypsin. All of the TbpB 
expressed in the absence of TbpA was readily accessible to trypsin; however in the wild type 
receptor there is some TbpB that is resistant to cleavage by trypsin (48). The presence of 
TbpA partially protected TbpB from trypsin proteolysis, and TbpB also protected TbpA from 
trypsin exposure. These observations indicate that TbpA and TbpB function together in the 
wild-type strain, to evoke binding conformations that are distinct from those expressed by the 
mutants lacking either protein. Protease accessibility experiments suggested that the 
conformation or exposure of TbpB was dependent upon the presence of TbpA, consistent 
with the hypothesis that the two proteins interact with each other (48). 
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Like its meningococcal homolog (89), gonococcal Sarkosyl-solubilized TbpB could be 
affinity purified (by transferrin) in the presence of TbpA, but not in absence of TbpA, 
suggesting that TbpB might have bound to transferrin through TbpA under these conditions 
(96). Alternatively, TbpB in the absence of TbpA may have adopted a different conformation 
so that it no longer bound to transferrin in Sarkosyl. Under the same conditions, when TbpB 
does not bind transferrin, affinity chromatography could help in the co-purification and 
increase in the yield of TbpA-TbpB (96, 97). The altered properties shown by the proteins in 
the affinity purification assay suggest that TbpA and TbpB appear to interact with one 
another in wildtype gonococci. 
Binding assays clearly depicted that the binding affinities of individual Tbps are different 
from the intact receptor comprising of both of the Tbps (48). It was shown that the binding 
characteristics of the wildtype receptor were described better using a two-site model. In 
contrast, mutant gonococcal strains expressing only TbpA or mutant strain expressing only 
TbpB exhibited binding affinities which were described by a single binding site model (48). 
These results indicate that TbpA and TbpB when expressed independently in the mutants 
bound transferrin with relatively high affinity in the liquid-phase binding experiments. 
Analysis of the mutants indicated that neither protein expressed individually bound 
transferrin with binding parameters that approximated those of the wild-type strain. This 
suggested that the wild-type binding phenomena resulted from the combination of TbpA and 
TbpB at the cell surface (48). This might allow us to say that TbpA and TbpB interact with 
one another on the cell surface such that it leads to unique conformation and transferrin 
interaction of the combined receptor complex. 
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Studies with TbpA mutants in the TonB box of TbpA showed that these mutations had an 
effect on the conformation of TbpB, implying that TbpA-TbpB interact on the gonococcal 
cell surface (54, 158). To help define the individual roles of these receptors in the process of 
transferrin-iron acquisition, the kinetics of the receptor proteins in regards to ligand 
association and dissociation were evaluated. Both TbpA and TbpB demonstrated a two-phase 
release pattern; however, TbpA required both TonB and TbpB for efficient transferrin 
dissociation from the cell surface. Looking further into the roles of TbpA and TbpB in 
transferrin dissociation it was proposed that TbpA and TbpB function synergistically during 
the process of transferrin iron acquisition and that TbpB makes the process of transferrin-iron 
acquisition more efficient at least in part by affecting association and dissociation of 
transferrin from the cell surface (64). 
All the above observations provide indirect evidence of interaction between TbpA and 
TbpB. There are a number of different techniques to show direct interaction between 
corresponding protein partners. In order to directly demonstrate an interaction event between 
TbpA and TbpB we chose to utilize crosslinking assays. We used photo-activable 
crosslinkers to probe the impact that TbpA has on the migration and conformation of TbpB.  
Crosslinking reagents provide the means for capturing in-vivo protein-protein complexes 
by covalently binding them together as they interact. The rapid action of the common 
functional groups on crosslinkers allows even transient interactions to be frozen in place or  
weakly interacting molecules to be seized in a complex stable enough for isolation and 
characterization. Cross-linking experiments (in conjunction with immunoprecipitation) have 
been utilized to identify major proteins of the gonococcal outer membrane that are 
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responsible for imparting serotypic specificity (125), and yield information about the 
antigenicity of surface-exposed,  outer membrane gonococcal proteins (205, 206). 
Sophisticated crosslinker designs have been created that incorporate photoreactive 
groups, which react only in response to irradiation by UV light. We utilized L-photo-Leucine 
and L-Photo-Methionine. These are photoreactive derivatives of amino acids and during 
bacterial growth, proteins get metabolically labeled. Upon UV-irradiation, at specific time 
points, the proteins get covalently crosslinked within protein-protein interaction domains in 
their native environment in live cells. This method enables both stable and transient protein 
interactions in cells to be studied and characterized without the use of completely foreign 
chemical crosslinkers and associated reagent solvents during the interaction experiment that 
can adversely aspects of the cell biology being studied. These photo-activable amino acids 
have several advantages: 
 In vivo labeling of proteins using normal cellular machinery of metabolically 
active cells. 
 In vivo crosslinking of interacting proteins in the native cellular environment.  
 Increased specificity as proteins correctly positioned at their interfaces within 
protein interaction domains are crosslinked.  
 Efficient recovery after crosslinking.  
 Compatible and easy to use as they are photo-stable. 
 
 
When used in combination with specially formulated limiting media that is devoid of 
leucine and methionine, the photo-activable derivatives are treated like naturally 
occurring amino acids by the protein synthesis machinery within the cell. As a result, 
they can be substituted for leucine or methionine in the primary sequence of proteins 
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during catabolism and growth. Photo-Leucine and Photo-Methionine derivatives contain 
diazirine rings that activate when exposed to UV light to become reactive intermediates 
that form covalent bonds with nearby protein side chains and backbones. Naturally 
associating binding partners within the cell can be instantly trapped by photoactivation of 
the diazirine-containing proteins in the cultured cells. Crosslinked protein complexes can 
be detected by decreased mobility on SDS-PAGE followed by Western blot detection. 
Based on earlier work, using computer predictions and similarity with other TonB-
dependent transporters, for which crystal structures have been determined, a hypothetical 
model was proposed for gonococcal TbpA (20, 129). To investigate the surface-exposed 
regions in TbpA, the Hemagglutinin (HA) epitope tag was inserted to create site-directed 
mutants and the functional impacts of this mutagenesis were investigated. Of these 
mutants, insertions into putative loops 2, 9, and 11 resulted in variants that bound 
transferrin with wild-type affinity but could complete the iron acquisition process only in 
the presence of a functional TbpB protein (20), which supports the contention that TbpA 
and TbpB interact on the cell surface and could implicate putative loops 2, 9, and 11 as 
contributors to a TbpA-TbpB interaction. Another TbpA mutant was created by targeting 
the conserved motif in the plug domain. The triple alanine substitution mutant in TbpA 
maintained wild type transferrin binding affinity (153). The mutant was unable to grow 
on transferrin as a sole source of iron but TbpB expression compensated for this defect. 
We are interested in investigating the characteristics of these mutants in terms of an 
interaction between TbpA and TbpB, using photo-activable crosslinkers. Table 4 lists the 
selected mutants to be studied, and Table 5 depicts the transferrin binding and growth 
capabilities of these mutants. 
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We hypothesize that TbpA and TbpB interact on the gonococcal cell surface. We 
believe that certain residues of TbpA and TbpB are important for the interaction between 
the two proteins.  We would like to demonstrate the interaction between TbpA and TbpB 
and assess the factors which play a role in the interactive abilities between these two 
proteins, namely the presence of ligand and TonB derived energy. 
This study will aid in better visualization of key structure-function relationships in the 
gonococcal transferrin binding proteins. Knowledge about the transferrin receptor 
complex, will give us a better understanding as to how these proteins function and the 
characteristics of the receptor that are expressed in the bacteria.  
 
 
 
 
 
 
 
 
 
 
 
 
65 
 
 
     
 
                                                                     
Table 4: HA-insertion mutants in TbpA selected for this study 
 
 
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strains Relevant characteristics References 
MCV515 L9HA(750) TbpA Lbp
- 
(tbpA HA lbpB::Ω) 238 
MCV519 L11HA(843) ΔAla847 TbpA Lbp
- 
(tbpA HA lbpB::Ω) 238 
MCV527 L2HA(229) TbpA Lbp
- 
(tbpA HA lbpB::Ω) 238 
MCV260 TbpAE120AY121AE122ATbpB
+
 153 
MCV511 L3HA(343) TbpA Lbp
−
 (tbpA∇HA lbpB::Ω) 238 
MCV505 L5HA(509) TbpA Lbp
−
 (tbpA∇HA lbpB::Ω) 238 
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Table 5: Transferrin binding and growth capabilities of the selected site specific mutants in 
transferrin receptor components. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mutant 
Transferrin binding 
in presence of 
TbpB 
Growth on 
transferrin in 
presence of TbpB 
Transferrin-iron 
uptake in presence 
of TbpB 
MCV515 + + Not Determined 
MCV519 + + Not Determined 
MCV527 + + Not Determined 
MCV260 + + + 
MCV511 - - Not determined 
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II. RESULTS: 
 
 
A. Identification of interaction between TbpA and TbpB 
 
To study the effect of photo crosslinking on TbpA-TbpB interaction, gonococci 
were grown with photo-activable cross-linkers under iron depleted conditions. Interacting 
proteins, including the Tbps which are hypothesized to be situated extremely close to 
each other on the gonococcal cell surface would then be cross-linked by UV exposure. 
The shift or change in protein molecular mass was visualized by running protein samples 
on SDS-PAGE gels and transferred to nitrocellulose membrane. TbpA was detected using 
antibodies against TbpA and wild-type sized TbpB was detected by ligand-binding blot. 
As an evidence of cross-linking of TbpA-TbpB, we measured the loss of full-length 
TbpB. In the wild type strain we observed loss of TbpB under photo cross-linking 
conditions (figure 5 and 6); however we didn’t detect specific higher molecular weight 
(>200 kDa, cross-linked) protein complexes due to their inability to migrate through the 
SDS-PAGE gel. In FA19 (the wild-type strain) photoactivation resulted in the formation 
of multiple cross-linked protein species containing TbpA (seen in lane 2 of figure 5A) 
and in the ligand binding blot it resulted in the loss of wild-type sized TbpB.   We 
measured loss of full-length TbpB as an indication of TbpA-TbpB interaction. The loss of 
TbpB after photo crosslinking is shown graphically in figure 6. To check for specificity 
in terms of a potential interaction between Tbps, we used a tbpA
- 
mutant gonococcal 
strain for analysis. In the tbpA mutant (FA6747), the wild-type TbpB protein was  
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detectable to the same degree with and without photoactivation (figure 5B and figure 6), 
indicating that the change in migration of TbpB was dependent upon the presence of 
TbpA.  Photo-crosslinking altered TbpB migration, only in the presence of TbpA. 
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Figure 5: TbpA and TbpB detection in crosslinked samples of wildtype and TbpA mutant. 
Gonococcal strains FA19 (wild type), and FA6747 (TbpA
-
 mutant) were grown under iron-
depleted conditions in the presence of photo-activable cross-linkers. Cultures were UV irradiated 
and whole cell lysates were prepared. Proteins were separated by SDS-PAGE and transferred to 
nitrocellulose. Blots were probed with α-TbpA serum (A) to detect TbpA, and hTf-HRP (B) to 
detect TbpB. Samples that were UV exposed are labeled as (+) and non-UV exposed are labeled 
as (-). 
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Figure 5: Quantification of TbpB in the wildtype and TbpA mutant. TbpB was detected by 
ligand-binding blot, and expressed as percent of TbpB that remains at the wild-type molecular 
mass after cross-linking. Samples that are UV exposed are signified as UV (+) and that are non-
UV exposed are noted as UV (-).  
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B. Investigation of TbpA-TbpB interaction in HA-TbpA mutant 
We tested selected HA insertion mutants (in the surface exposed loops of 
TbpA), to investigate whether they were competent for interaction between TbpA 
and TbpB. We selected loop mutants in positions L2, L3, L5, L9, L11 to be tested 
for studying the effect of crosslinking on interaction between TbpA and TbpB. 
Insertions into putative loops 2, 9, and 11 resulted in mutants that bound 
transferrin with wild-type affinity but could complete the iron acquisition process 
only in the presence of a functional TbpB protein (238). TbpB compensates for a 
surface exposed mutation in TbpA; this implicates loops 2, 9, and 11 as 
contributors to a TbpA-TbpB interaction. When we conducted ligand blot 
analysis, the results showed that the TbpA-TbpB interactions between the wild 
type strain and the loop 2 mutant (depicted in figures 7), loop 9 mutant (figures 9) 
and the loop 11 mutants (figures 11), were similar. Graphical representation of % 
of TbpB remaining after photo crosslinking gave similar results between the wild 
type and loop 2 (figure 8), loop 9 (figure 10) and loop 11 (figure 12) mutants.  
Previous deletion data indicated that L5 contains residues essential for 
transferrin binding and utilization (20). The L5 HA-TbpA was unaffected in 
ligand binding or transferrin-iron utilization. We chose to look at the TbpB 
interaction abilities of the TbpA loop 5 HA mutant. 
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Figure 7: TbpA and TbpB detection in crosslinked samples of wildtype and L2 HA-TbpA 
mutant. Gonococcal strains FA19 (wild type), and MCV527 (L2 HA-TbpA mutant) were grown 
under iron-depleted conditions in the presence of photo-activable cross-linkers. Cultures were 
UV irradiated and whole cell lysates were prepared. Proteins were separated by SDS-PAGE and 
transferred to nitrocellulose. Blots were probed with α-TbpA serum (A) to detect TbpA, and hTf-
HRP (B) to detect TbpB. Samples that were UV exposed are labeled as (+) and non-UV exposed 
are labeled as (-). 
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Figure 8: Quantification of TbpB in the wildtype and L2 HA-TbpA mutant. TbpB was 
detected by ligand-binding blot, and expressed as percent of TbpB that remains at the wild-type 
molecular mass after cross-linking. Samples that are UV exposed are signified as UV (+) and 
that are non-UV exposed are noted as UV(-). 
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Figure 9: TbpA and TbpB detection in crosslinked samples of wildtype and L9 HA-TbpA 
mutant. Gonococcal strains FA19 (wild type), and MCV515 (L9 HA-TbpA mutant) were grown 
under iron-depleted conditions in the presence of photo-activable cross-linkers. Cultures were 
UV irradiated and whole cell lysates were prepared. Proteins were separated by SDS-PAGE and 
transferred to nitrocellulose. Blots were probed with α-TbpA serum (A) to detect TbpA, and hTf-
HRP (B) to detect TbpB. Samples that were UV exposed are labeled as (+) and non-UV exposed 
are labeled as (-). 
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Figure 10: Quantification of TbpB in the wildtype and L9 HA-TbpA mutant. TbpB was 
detected by ligand-binding blot, and expressed as percent of TbpB that remains at the wild-type 
molecular mass after cross-linking. Samples that are UV exposed are signified as UV (+) and 
that are non-UV exposed are noted as UV(-). 
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Figure 11: TbpA and TbpB detection in crosslinked samples of wildtype and L11 HA-
TbpA mutant. Gonococcal strains FA19 (wild type), and MCV519 (L11 HA-TbpA mutant) 
were grown under iron-depleted conditions in the presence of photo-activable cross-linkers. 
Cultures were UV irradiated and whole cell lysates were prepared. Proteins were separated by 
SDS-PAGE and transferred to nitrocellulose. Blots were probed with α-TbpA serum (A) to 
detect TbpA, and hTf-HRP (B) to detect TbpB. Samples that were UV exposed are labeled as (+) 
and non-UV exposed are labeled as (-). 
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Figure 12: Quantification of TbpB in the wildtype and L11 HA-TbpA mutant. TbpB was 
detected by ligand-binding blot, and expressed as percent of TbpB that remains at the wild-type 
molecular mass after cross-linking. Samples that are UV exposed are signified as UV (+) and 
that are non-UV exposed are noted as UV(-). 
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Upon photo crosslinking, we observed that the L5 HA-TbpA mutant behaved in a 
similar manner to the wild type strain, with the TbpB migration changed after UV 
irradiation being similar between the wild type and the mutant (figures 12 and 13). 
The L3HA mutant was not capable of transferrin binding; it was also unable to 
mediate the transferrin-iron uptake process. That makes the mutant interesting to study, 
since the inability to utilize transferrin-iron underlines the importance of this region. We 
found that the migration of TbpB after crosslinking in the L3 HA-TbpA mutant was 
similar to the wildtype (figures 15 and 16). 
Previously in our lab, we created a TbpA triple alanine substitution mutant in a 
conserved motif of TbpA plug, with the intention of finding residues in TbpA important 
for iron utilization. This TbpA triple alanine mutant was defective in transferrin-iron 
uptake and utilization (153). To test the capability of this mutated TbpA plug to interact 
with wild type TbpB, we conducted photo crosslinking assays with this mutant. The 
results showed similarity between the TbpB migration after photo crosslinking between 
the wild type and the TbpA triple alanine mutant (figures 17 and 18). 
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Figure 13: TbpA and TbpB detection in crosslinked samples of wildtype and L5 HA-TbpA 
mutant. Gonococcal strains FA19 (wild type), and MCV505 (L5 HA-TbpA mutant) were grown 
under iron-depleted conditions in the presence of photo-activable cross-linkers. Cultures were 
UV irradiated and whole cell lysates were prepared. Proteins were separated by SDS-PAGE and 
transferred to nitrocellulose. Blots were probed with α-TbpA serum (A) to detect TbpA, and hTf-
HRP (B) to detect TbpB. Samples that were UV exposed are labeled as (+) and non-UV exposed 
are labeled as (-). 
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Figure 14: Quantification of TbpB in the wildtype and L5 HA-TbpA mutant. TbpB was 
detected by ligand-binding blot, and expressed as percent of TbpB that remains at the wild-type 
molecular mass after cross-linking. Samples that are UV exposed are signified as UV (+) and 
that are non-UV exposed are noted as UV(-). 
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Figure 15: TbpA and TbpB detection in crosslinked samples of wildtype and L3 HA-TbpA 
mutant. Gonococcal strains FA19 (wild type), and MCV511 (L3 HA-TbpA mutant) were grown 
under iron-depleted conditions in the presence of photo-activable cross-linkers. Cultures were 
UV irradiated and whole cell lysates were prepared. Proteins were separated by SDS-PAGE and 
transferred to nitrocellulose. Blots were probed with α-TbpA serum (A) to detect TbpA, and hTf-
HRP (B) to detect TbpB. Samples that were UV exposed are labeled as (+) and non-UV exposed 
are labeled as (-). 
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Figure 16: Quantification of TbpB in the wildtype and L3 HA-TbpA mutant. TbpB was 
detected by ligand-binding blot, and expressed as percent of TbpB that remains at the wild-type 
molecular mass after cross-linking. Samples that are UV exposed are signified as UV (+) and 
that are non-UV exposed are noted as UV(-). 
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Figure 17: TbpA and TbpB detection in crosslinked samples of wildtype and TbpA plug 
mutant. Gonococcal strains FA19 (wild type), and MCV260 (TbpA plug mutant) were grown 
under iron-depleted conditions in the presence of photo-activable cross-linkers. Cultures were 
UV irradiated and whole cell lysates were prepared. Proteins were separated by SDS-PAGE and 
transferred to nitrocellulose. Blots were probed with α-TbpA serum (A) to detect TbpA, and hTf-
HRP (B) to detect TbpB. Samples that were UV exposed are labeled as (+) and non-UV exposed 
are labeled as (-). 
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Figure 18: Quantification of TbpB in the wildtype and TbpA plug mutant. TbpB was 
detected by ligand-binding blot, and expressed as percent of TbpB that remains at the wild-type 
molecular mass after cross-linking. Samples that are UV exposed are signified as UV (+) and 
that are non-UV exposed are noted as UV(-). 
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C. Effect of ligand addition on TbpA-TbpB interaction 
 
To assess the effect of addition of ligand to the interaction between the Tbps, we added 
30% iron-saturated human transferrin to our photo crosslinkers containing iron depleted 
media and allowed for the wildtype gonococcal strain to grow in presence of ligand. 
TbpA presence was detected by using polyclonal antibodies against TbpA. The banding 
pattern in presence of ligand did not change much from what was observed without it. 
The reduction of TbpB after photo crosslinking was similar for both the conditions 
(figures 19 and 20). Binding of ligand does not alter the interaction between the Tbps in 
the wildtype. 
 
D. Effect of TonB derived energy on the TbpA-TbpB interaction 
 
We next tested the TonB mutant, by growing the mutant gonococcal strain with photo 
crosslinkers. We found that the TbpA immunoblots were similar between the wildtype 
and the TonB mutant in terms of detecting TbpA under non crosslinked and crosslinked 
conditions (figure  21-A). The amount of TbpB remaining after crosslinking is also 
similar between the wildtype and the TonB mutant (figure 21-B and 22). This indicates 
that there is interaction occurring between the Tbps, in the TonB mutant strain, implying 
that the interaction was demonstrated in the absence of TonB derived energy.  
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Figure 19: TbpA and TbpB detection in crosslinked samples of wildtype strain in absence 
and presence of transferrin. Gonococcal strain FA19 (wild type) was grown under iron-
depleted conditions in the presence of photo-activable cross-linkers, with or without the addition 
of human transferrin. Cultures were UV irradiated and whole cell lysates were prepared. Proteins 
were separated by SDS-PAGE and transferred to nitrocellulose. Blots were probed with α-TbpA 
serum (A) to detect TbpA, and hTf-HRP (B) to detect TbpB. Samples that were UV exposed are 
labeled as (+) and non-UV exposed are labeled as (-). 
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Figure 20: Quantification of TbpB in the wildtype strain in absence and presence of 
transferrin. TbpB was detected by ligand-binding blot, and expressed as percent of TbpB that 
remains at the wild-type molecular mass after cross-linking. Samples that are UV exposed are 
signified as UV (+) and that are non-UV exposed are noted as UV(-). 
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Figure 21: TbpA and TbpB detection in crosslinked samples of wildtype and TonB mutant. 
Gonococcal strains FA19 (wild type), and MCV650 (TonB mutant) were grown under iron-
depleted conditions in the presence of photo-activable cross-linkers. Cultures were UV irradiated 
and whole cell lysates were prepared. Proteins were separated by SDS-PAGE and transferred to 
nitrocellulose. Blots were probed with α-TbpA serum (A) to detect TbpA, and hTf-HRP (B) to 
detect TbpB. Samples that were UV exposed are labeled as (+) and non-UV exposed are labeled 
as (-). 
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Figure 22: Quantification of TbpB in the wildtype and TonB mutant strains. TbpB was 
detected by ligand-binding blot, and expressed as percent of TbpB that remains at the wild-type 
molecular mass after cross-linking. Samples that are UV exposed are signified as UV (+) and 
that are non-UV exposed are noted as UV(-). 
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When we added ligand (30% iron-saturated transferrin) to the TonB mutant strain 
while growing with photo crosslinkers, we found that the amount of TbpB detected in the 
TonB mutant, in crosslinked and non-crosslinked conditions remains the same (figures 23 
and 24). This is in sharp contrast to what we observed for the wildtype strain where under 
photo crosslinking condition there was loss of wildtype sized TbpB. The loss of TbpB 
due to crosslinking indicates an interaction between TbpA-TbpB in the wildtype and the 
above results indicate that in the TonB mutants addition of transferrin prevents the 
interaction between TbpA-TbpB.  
Overall the data suggests that photo-crosslinking altered TbpB migration, only in 
the presence of TbpA. Upon addition of transferrin, we observed no significant difference 
in the TbpA-TbpB interaction. The HA epitope insertions in TbpA do not seem to cause 
disruption in TbpA-TbpB interaction. Binding of ligand does not alter the interaction 
between the Tbps in the wildtype, similar to the result when a TonB mutant was used for 
analysis, indicating that the TbpA-TbpB interaction is independent of TonB derived 
energy. However in the de-energized system, addition of ligand prevented TbpA-TbpB 
interaction.  
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Figure 23: TbpA and TbpB detection in crosslinked samples of wildtype and TonB mutant 
strains in presence of transferrin. Gonococcal TonB mutant strain was grown under iron-
depleted conditions in the presence of photo-activable cross-linkers, with addition of human 
transferrin. Cultures were UV irradiated and whole cell lysates were prepared. Proteins were 
separated by SDS-PAGE and transferred to nitrocellulose. Blots were probed with α-TbpA 
serum (A) to detect TbpA, and hTf-HRP (B) to detect TbpB. Samples that were UV exposed are 
labeled as (+) and non-UV exposed are labeled as (-). 
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Figure 24: Quantification of TbpB in the wildtype and TonB mutant strains in presence of 
transferrin. TbpB was detected by ligand-binding blot, and expressed as percent of TbpB that 
remains at the wild-type molecular mass after cross-linking. Samples that are UV exposed are 
signified as UV (+) and that are non-UV exposed are noted as UV(-). 
 
 
 
 
 
 
 
 
 
 
 
 
 
112 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
113 
 
 
 
 
III. DISCUSSION 
 
Several studies aimed at elucidating the structural and functional characteristics of the 
transferrin binding proteins have shown that the presence or absence of TbpA has a profound 
effect on the functionality of TbpB. A TonB-box mutation in TbpA showed that the 
energization state of TbpA had an effect on the protease accessibility of TbpB (48, 54).  
These observations suggested that both Tbps are in close proximity of one another on the 
cellular surface, and the TbpA energy-induced conformational change in TbpB could imply 
that TbpA and TbpB interact on the gonococcal surface. Co-immunoprecipitation assays 
conducted with the outer membrane fractions of gonococcal strains, led to the co-
immunoprecipitation of TbpB using TbpA-specific antibodies (96). This suggests that there 
is some population of TbpB that interacts with TbpA on the cell surface.  
We hypothesized that the presence of TbpA impacts the exposure or conformation of 
TbpB. In this study, we have utilized photoactivable cross-linkers to assess the effect of 
TbpA on TbpB in live gonococcal cells and studied it in the presence of ligand and TonB 
derived energy. We employed insertion mutants, in which TbpA contained the hemagglutinin 
(HA) epitope tag, to probe for the impact of TbpA mutagenesis on TbpB. The crosslinking 
approach has been successfully used before to study the interaction and recognition residues 
between E. coli periplasmic protein partners, CusF and CusB (127). These two proteins are 
part of the CusCFBA efflux system, which is involved in the metal extrusion from the 
periplasm to the extracellular space. The structural details of the interactions 
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between CusF and CusB were mapped through chemical cross-linking, coupled with high-
resolution mass spectrometry (127). 
In our study, photo crosslinking experiments demonstrated that in the wildtype 
gonococcal strain there was loss of wildtype size TbpB; this was absent in the TbpA mutant 
strain. Our results demonstrate that photo-cross-linking altered TbpB size and migration and 
was dependent on the presence of TbpA. HA epitope insertion mutants in surface exposed 
loops of TbpA did not impact the mobility of cross-linked TbpB. It was demonstrated that 
insertions into putative loops 2, 9, and 11 resulted in mutants that bound transferrin with 
wild-type affinity but could complete the iron acquisition process only in the presence of a 
functional TbpB protein (238). This suggests that TbpB can compensate for a mutation in 
TbpA, resulting in a functional receptor. Because TbpB is exposed on the outer membrane, 
the compensatory function of TbpB for overcoming the defect is bound to be on the cellular 
surface. This implicates putative loops 2, 9, and 11 as contributors to a TbpA-TbpB 
interaction. Our results indicate that the these loop 2, 9 ,11 mutants showed no hampering of 
the TbpA-TbpB interaction. These loops might not contribute to the interaction between the 
Tbps in the gonococci.  The L3HA mutant was incapable of transferrin binding, (this mutant 
was stuck at the first step of transferrin-iron utilization process), and it was unable to mediate 
the iron uptake process, which is not surprising since the initial step of the process could not 
be accomplished (238). This indicates that L3 region could be important for transferrin 
binding and transferrin-iron acquisition process. This observation helped us choose the L3 
HA mutant for analysis of the TbpA-TbpB interaction. Photo crosslinking experiments 
showed that the TbpA-TbpB interaction was not affected in this mutant and indicates that L3 
might not be involved in the TbpA-TbpB interaction. In the L5HA mutant the insertion 
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region for the HA epitope tag was a variable region of TbpA. This mutant was unaffected in 
ligand binding or transferrin-iron utilization, and as per our crosslinking analysis it was 
unaffected in the TbpA-TbpB interaction. This might indicate that variable, surface-exposed 
residues are not critical for the function of the receptor but may be important for immune 
evasion and camouflage of the underlying conserved binding epitopes. 
The triple alanine substitution mutants demonstrated decreased transferrin-iron 
internalization and maintained the ability to utilize transferrin as a sole iron source, only in 
the presence of TbpB (153), suggesting that for TbpB to compensate for TbpA mutation they 
may have to interact for this process. However this mutant also demonstrated no disruption 
of the TbpA-TbpB interaction in our study. This region of the plug might not play an 
important role in the interaction between the Tbps; however the plug does bind iron during 
the iron acquisition process (chapter 1). 
Creation of a TonB mutant (54) allowed us to investigate the effect of energy status on 
TbpA-TbpB interaction. Performing the crosslinking assay with the TonB mutants (both in 
absence and presence of ligand) enabled us to make key observations with the TbpA-TbpB 
interactions. In the TonB mutants, we observed that the de-energized state resulted in 
wildtype TbpA and TbpB migration after cross-linking. Addition of ligand to the wild type 
strain did not hamper the Tbps’ interaction. However the addition of human transferrin to the 
de-energized mutant caused a change in TbpB migration after cross-linking. This result 
indicates that when ligand is bound tightly and irreversibly to TbpA, the accessibility and 
perhaps conformation of TbpB is altered.  
In the TonB box mutants, TbpB seemed to show a difference in protease susceptibility 
assays indicating an energy-induced conformational change in TbpB (54). This observation 
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allowed the conclusion that the energization state of TbpA resulted in a conformational 
change in TbpB, consistent with a physical interaction between the two outer membrane 
proteins. It was speculated that the transient TbpA-TbpB interaction occurs only when TbpA 
is energized. To illustrate our findings in context of the gonococcal transferrin mediated iron 
acquisition system, we present two models (figure 25-A and 25-B) to put forth a possible 
topology model  for the difference in TbpB mobility and interaction with TbpA in a de-
energized mutant. In presence of ligand, when TonB energizes TbpA, TbpA interacts with 
TbpB, impacting its migration following crosslinking. When ligand is locked on TbpA 
(occurs when TbpA is de-energized in a tonB mutant), TbpA cannot interact with TbpB. Our 
in vivo studies suggest that in presence of ligand, de-energized TbpA does not interact with 
TbpB. 
Our conclusions from the crosslinking assays and its effects on TbpA-TbpB interactions 
have been confirmed by the recent crystal structures of the homologous meningococcal 
proteins (150, 151). These structural studies of TbpA-TbpB-ligand triple complex illustrate 
that Tbps bind ligand through unique, non-over lapping binding sites such that TbpA and 
TbpB do not interact. The X-ray, SAXS and EM structures support a consistent arrangement 
for the TbpA–TbpB–(holo)hTF complex, where TbpA and TbpB bind through unique, non-
overlapping sites to assemble a triple complex. This assembled tri-complex encloses a 
chamber at the union of the three protein components, and the TbpA and TbpB do not seem 
to interact even though the walls of this chamber are comprised of TbpA-TbpB-hTf. 
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Figure 25: Model of conformational change in the gonococcal transferrin binding proteins. 
The gonococcal envelope consisting of outer membrane (OM), periplasm and inner membrane 
(IM) is shown, along with the proteins constituting the transferrin mediated iron acquisition 
pathway. Part (A) shows the model for conformation of the Tbps in energized state, after 
crosslinking, and in part (B) the conformations during the de-energized conditions are shown. In 
part (A), complex of TonB, ExbB, ExbD in the inner membrane transmits energy to TonB-
dependent TbpA. When TbpA is energized and ligand is present, then upon crosslinking, TbpA 
interacts with TbpB and after iron extraction, apo-transferrin is recycled from the cell surface; 
this affects the migration pattern of TbpB. When TbpA is de-energized (figure 21 part B), the 
ligand gets locked onto TbpA, and this does not allow TbpA and TbpB to interact  
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CHAPTER 5: CONTRIBUTION OF TbpB DOMAINS TO INTERACTION BETWEEN 
GONOCOCCAL TRANSFERRIN BINDING PROTEINS 
 
I. INTRODUCTION 
Pathogenic Gram-negative bacteria rely on the surface-exposed transferrin 
receptor complex to acquire iron from host transferrin. TbpB, the second protein 
component of the gonococcal transferrin receptor is a surface exposed lipoprotein.    
TbpB is not required for iron internalization in the process of Tf-iron acquisition; it 
makes the process more efficient. The exact mechanism by which efficiency is enhanced 
is not known but a number of key studies have pointed out the importance of TbpB in 
transferrin mediated iron acquisition process. TbpB increases the efficiency by its ability 
to differentiate between apo- and holo-transferrin. Utilizing the relative transferrin-
binding properties of both Tbps, it was showed that TbpB discriminated between ferrated 
transferrin and apo-transferrin, while TbpA did not (48). In solid-phase binding assays 
with isolated membranes, TbpA was shown to bind both apo and iron-loaded transferrin, 
however TbpB discriminated between apo and holo transferrin. In binding assays with 
TbpB and recombinant fusion proteins, it was observed that both intact TbpB and the N-
terminal half of TbpB, preferentially bound iron-loaded transferrin (173). A mutant with 
deletion of tbpB,  but expressing wild-type levels of TbpA, showed reduced binding and 
iron uptake from transferrin,  but normal growth on transferrin plates. Mutants expressing 
only TbpB bound less transferrin, and did not take up iron from transferrin nor did they 
grow on transferrin plates. These results suggest that TbpB facilitates binding of 
transferrin but is not essential for acquisition of iron from transferrin (1).  
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To help understand the role of TbpB in transferrin iron utilization, a previous 
study in our lab evaluated the kinetics of the receptor proteins with regards to ligand 
association and dissociation (64). Transferrin association with TbpB was rapid as 
compared to TbpA. TbpA required both TonB and TbpB for efficient transferrin 
dissociation from the cell surface. It was proposed that TbpB makes the process of Tf-
iron acquisition more efficient at least in part by affecting association and dissociation of 
transferrin from the cell surface (64). Using the SUPREX technique, for assessing the 
thermodynamic stability of protein –ligand complexes, it was reported that TbpB 
(individually or along with TbpA) can deferrate transferrin without energy supplied from 
TonB resulting in sequestration by apo-FbpA (191).  
Recently X-ray crystallography, small-angle X-ray scattering and electron 
microscopy methods were used to look at the TbpB receptor from two N. meningitidis 
strains in its apo form and in complex with human transferrin (31, 151). This analysis 
was undertaken to elucidate how TbpA and TbpB function in binding human transferrin 
selectively and extract its tightly bound iron at physiological pH. TbpB is a bilobed 
protein; the two lobes are structurally similar. The N-terminal and C-terminal lobe are 
each subdivided into a 8-stranded β-barrel domain and an adjacent β-rich handle domain. 
The TbpB structures aligned closely with three TbpB structures from porcine pathogens 
(32, 136) and N-lobe of TbpB showed the major sequence and conformational variations. 
Residues affecting transferrin binding were situated on the distal surface of the N lobe 
(32, 50, 136, 192) and confer much of the transferrin species specificity. TbpB primarily 
binds the C lobe of human transferrin through its N lobe (151). It was also demonstrated 
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that the major site of interaction lies in the N lobe. TbpB stabilizes holo-human 
transferrin C-lobe by recruiting and sequestering holo- transferrin and maintains the iron-
loaded status of transferrin until its delivery to TbpA.   
To look at regions important in TbpB for transferrin binding and transferrin-iron 
uptake, HA epitope tagging was used. Nine insertion mutants were created, placing the 
HA epitope downstream of the signal peptidase II cleavage site and the impact of each 
insertion on the function of TbpB and the transferrin acquisition process was examined. 
The results showed that both the TbpB lobes (N-terminal and C-terminal lobes) are 
critical for efficient iron uptake from human transferrin (62, 150). These conclusions 
were further strengthened by studies with TbpB from Neisseria meningitidis, which 
showed that both N- and C-terminal domains together interact with human transferrin 
(171).  These findings point out one of TbpB’s contribution in the efficient binding of 
TbpB to human transferrin and thereby increasing the efficiency of the transferrin-iron 
acquisition pathway.  
TbpB proteins are heterogeneous, with 69 to 84% sequence identity among 
Neisseria gonorrhoeae strains and 64 to 75% identity when gonococcal TbpB proteins 
are compared to those of Neisseria meningitidis (50). Regions of conservation have also 
been demonstrated between TbpB proteins of N. gonorrhoeae, Actinobacillus 
pleuropneumoniae, and Moraxella catarrhalis. Sequence analysis revealed conserved 
regions interspersed within hypervariable domains of TbpB (172, 176). It is unclear as to 
how or what portions of TbpB are involved in the protein's function.  
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One conserved region in TbpB is the LSAC region, located at the N-terminal 
domain of TbpB. This is a consensus sequence of lipoprotein modification/processing site 
of Leu-(Ala, Ser)-(Gly, Ala)-Cys at -3 to +1 positions, representing the cleavage region 
of 75% of lipoprotein signals in bacteria. Unmodified prolipoprotein with the consensus 
sequence undergoes sequential modification and processing, the steps involved are: prior 
to cleavage diacylglycerol group is transferred to the available sulfhydryl group of the 
cysteine,  after cleavage of the prolipoprotein the free amine group of cysteine is acylated 
by N-acyl transferase to form mature lipoprotein (81, 235).  The LSAC region located in 
the N-terminus of TbpB, contains the signal II peptidase cleavage site. This signal 
sequence is responsible for targeting TbpB through the inner membrane into the 
periplasm. The LSAC lipobox with the cysteine residue serves as the first amino acid in 
the mature lipoprotein and the site of lipidation.  
Located just two amino acids downstream of the LSAC site is the second region 
of interest, consisting of four glycine residues adjacent to each other. The importance of 
this conserved poly-glycine stretch has still not been determined. This study aims to 
determine the importance of the two, above mentioned conserved regions of TbpB (the 
LSAC motif and the poly-glycine stretch), and the effect of mutations (in these two 
regions) on the protein translocation, transferrin mediated iron utilization and TbpA-
TbpB interactions. HA epitope insertions mutants in homologous regions in the N-
terminal and C-terminal of TbpB were also used for investigating the interaction between 
the transferrin binding proteins, thereby enabling us to study the importance of these 
regions in the interaction between the transferrin binding proteins. 
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II. RESULTS 
Using alanine substitution mutagenesis, in gonococcal TbpB, the prototypical 
lipobox with the sequence LSAC was replaced with LAAA. The lipobox was replaced 
with a consensus signal I peptidase cleavage site. This would allow the cleavage and 
export of the lipoprotein but not the lipidation through the LSAC motif. The poly-glycine 
region in TbpB was deleted to create a glycine deletion mutant (TbpB Δgly). Both of 
these mutants were evaluated for lipidation and the translocation of the mature 
lipoprotein through the cytoplasmic membrane. Figure 26 depicts a linear model of 
TbpB, showing the LSAC and the glycine rich regions. This figure also shows the sites of 
HA4 and HA8 insertions in TbpB. 
A. LSAC mutation abolishes lipidation in TbpB and decreases the amount of 
detectable, cell-associated TbpB 
 
We determined the state of lipidation of TbpB. It was predicted that mutating 
LSAC (lipidation site) could lead to absence of lipidation in the LSAC mutant. Lipidation 
was prevented in the alanine substituted LSAC (LSAC-LAAA) mutant, whereas in the 
Δglycine mutant the lipidation that was observed was similar to what was observed in the 
wild type strain (figure 27, part A). These observations clearly point out that deletion of 
the poly-glycine stretch (2 amino acids downstream of the LSAC site) had no effect on 
lipidation, but the LSAC region is necessary for lipidation of TbpB.  
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Figure 26: Linear model of TbpB: the model depicts the N-lobe and C-lobe of the 
TbpB protein, with the LSAC site and the downstream glycine rich regions highlighted. 
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Figure 27: Effect of the LSAC mutation on TbpB lipidation and cellular localization. (A) 
Gonococci were grown under iron-depleted conditions in the presence of azide-labeled palmitic 
acid. Bacteria were lysed and azide-labeled proteins were conjugated to biotin-alkyne. Following 
separation by SDS-PAGE and transfer to nitrocellulose, proteins were probed with either anti-
TbpB antiserum or avidin-HRP. Control strains included FA19 (wild type) and FA6905 (TbpB
−
).  
(B) Gonococci were grown under iron-deplete conditions and harvested by centrifugation. The 
culture supernatant was treated with TCA to precipitate proteins. Following separation by SDS-
PAGE and transfer to nitrocellulose, membranes were probed using anti-TbpB antiserum.  Lanes 
labeled P contain proteins from the pelleted, whole cell fraction. Lanes labeled S contain proteins 
from the supernatant fraction. 
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With the absence of lipidation of the non-processed lipoprotein, it would seem 
difficult for the protein to be anchored to the outer membrane, due to the absence of a 
lipid moiety. To detect proteins released from the cell surface, TCA precipitation was 
conducted with the cell-free culture supernatant. Presence or absence of TbpB was 
investigated in the cellular pellet and the supernatant. In the wildtype strain most of 
the TbpB was present in the cell pellet, with less TbpB detected in the supernatant. 
The LSAC mutant showed some interesting results; majority of the TbpB was 
detected in the soluble fraction of the supernatant, lesser quantities of TbpB being 
detected in the cell pellet (figure 27, part B). This suggests that the absence of 
lipidation had no effect on the transport of TbpB across the outer membrane, but led 
to the absence of tethered-TbpB on the bacterial cell surface. 
B. TbpB is surface accessible in the Δgly mutant but less so in the LSAC mutant   
If the LSAC motif and the poly-glycine region played a role in the cellular 
transport to the surface, it would play a role in the surface exposure of the TbpB. To 
look at the surface accessibility of TbpB, protease accessibility assays were 
performed. The LSAC mutant upon exposure to trypsin, showed an absence of 
proteolytically digested (cell associated) products (figure 28). These results tell us 
that in the lipobox mutant, TbpB is not presented on the cellular surface and absence 
of cell-tethered TbpB peptides implies that the TbpB is not anchored to the 
gonococcal cell surface. In the Δglycine mutant, trypsin addition gave rise to  
 
 
130 
 
 
 
 
 
 
Figure 28: Surface exposure of TbpB.  Bacteria were grown under iron depleted conditions 
prior to exposure to trypsin. WCLs were prepared following 0, 15, or 30 minutes of trypsin 
digestion. Undigested samples (U) were also included as a control. Proteins were separated by 
SDS-PAGE, transferred to nitrocellulose, and probed with hTf-HRP. Strain FA19 was included 
as a wild-type control. 
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protease-digested, cell-associated, small peptide fragments; this observation was 
similar to the wild type (figure 28), indicating that the TbpB was functional and 
tethered to the outer membrane.   
C. Impact of TbpB mutagenesis on transferrin-iron transporter function 
To test transferrin-iron internalization by the LSAC and the Δglycine mutated 
TbpB, double mutants were created by moving each of these mutations separately 
into a TbpA L9HA background, and then testing these double mutants for growth on 
transferrin as the sole source of iron. Gonococcal strain MCV515 is unique in the 
sense that it is capable of growth on transferrin only when TbpB is expressed. The 
insertion of HA epitope tag in the loop 9 of TbpA somehow disrupts epitopes in 
TbpA such that iron internalization occurs only when wild type TbpB is present in the 
strain. The MCV515 strain was able to grow on transferrin, the tbpB knockout strain 
showed no growth; this was a similar trend in the TbpB LSAC mutant, which showed 
no growth in presence of transferrin (figure 29). The TbpB Δglycine mutant showed 
highly reduced growth, more easily deciphered at lower saturation levels of 
transferrin (figure 29). These data inform us that the LSAC and the Δglycine 
mutations in TbpB affect the iron-transferrin transporter function of TbpB.  
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Figure 29: Effect of TbpB mutations on transferrin-iron utilization. Gonococci were plated 
on CDM agarose plates containing human transferrin.  Strains tested include (clockwise, 
beginning at the top): (1) FA19 (WT), (2) FA6815 (A
-
B
-
), (3)MCV515 (L9HA), (4)MCV516 
(L9HA, B
-
),  (5) MCV858 (L9HA, LSAC), and (6) MCV860 (L9HA,  Δgly) 
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D. Mutations  of the conserved amino-terminal regions of TbpB does not impair 
interaction with TbpA 
We utilized the cross-linking assay to evaluate the effects of LSAC and Δglycine 
mutations on the TbpA-TbpB interaction. We incorporated photo-activable 
methionine and leucine, into iron-depleted growth medium; and allowed the bacterial 
strains to grow in presence of these cross-linkers. The cultures were UV exposed to 
allow for cross-linking of interacting proteins, and then we identified full-length 
TbpB using a ligand binding blot. As an evidence of cross-linking of TbpA-TbpB, we 
measured the loss of full-length TbpB. In the wild type strain we observed loss of 
TbpB under photo cross-linking conditions; however we didn’t detect any higher 
molecular weight (cross-linked) protein complexes due to their inability to traverse 
the SDS-PAGE gel. In the TbpA
-
 strain, we observed that the intensity of TbpB being 
detected was same both in non-cross-linked and cross-linked conditions, which 
indicated to us that TbpA expression was important for the change in migration of 
TbpB (figure 30). The LSAC and Δglycine mutants showed similar migration 
patterns for TbpB, when compared to each other and the wildtype strain. When we 
graphically measured the percentage of TbpB remaining after photo cross linking, we 
observed that the decrease in TbpB in both the mutants was similar to the wild type 
strain (figures 31 and 32). Even though the LSAC mutated TbpB was not anchored on 
the outer membrane, it still possessed the capability of interacting with TbpA.  
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Figure 30: TbpB detection in crosslinked samples of TbpB mutants. Gonococcal 
strains FA19 (wild type), FA6747 (TbpA
-
 mutant), MCV839 (LSAC mutant), and 
MCV843 (Δgly mutant) were grown under iron-depleted conditions in the presence of 
photo-activable cross-linkers. Cultures were UV irradiated and whole cell lysates were 
prepared. Proteins were separated by SDS-PAGE and transferred to nitrocellulose. TbpB 
was detected by probing the blots with HRP labeled Tf. Samples that were UV exposed 
are labeled as (+) and non-UV exposed are labeled as (-).  
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Figure 31: Quantification of TbpB in the wildtype and LSAC mutant. TbpB was 
detected by ligand-binding blot, and expressed as percent of TbpB that remains at the 
wild-type molecular mass after cross-linking. Samples that are UV exposed are signified 
as UV (+) and that are non-UV exposed are noted as UV (-). 
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Figure 32: Quantification of TbpB in the wildtype and Δgly mutant. TbpB was 
detected by ligand-binding blot, and expressed as percent of TbpB that remains at the 
wild-type molecular mass after cross-linking. Samples that are UV exposed are signified 
as UV (+) and that are non-UV exposed are noted as UV (-).  
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We also used the HA epitope insertion mutants in TbpB, in the cross-linking 
assays. The TbpA and TbpB blots, with the non-crosslinked and crosslinked samples, 
showed no difference between the wildtype strain and the HA4 mutant (part A and B in 
figure 33). In contrast, the HA8 mutant showed no reduction of wild type sized TbpA and 
TbpB (part A and B in figure 34) after crosslinking, unlike the wild type strain. 
Findings from this section suggest that the lipid-tether deficient TbpB and 
glycine-region deleted TbpB have not lost their capability of interacting with TbpA, 
despite mutations in conserved regions of TbpB. We observed that the HA insertions in 
positions 4 and 8 (depicted in figure 26) of TbpB protein, did not disrupt the interaction 
between the transferrin binding proteins. 
 
 
III. DISCUSSION 
Surface-exposed lipoproteins have been described in many Gram-negative bacteria, but 
the signals and machinery involved in their localization remain to be characterized (112, 114, 
159). In Neisseria, the cellular surface shows the presence of the lipoproteins (including 
TbpB), which are tethered to the outer leaflet of the outer membrane by a lipid moiety (62). 
Lipoproteins are also present in other gram-negative bacteria, like Klebsiella (145), 
Bordetella (56), and E. coli (166); the mechanism for the transport of these lipoproteins 
across the cellular membranes is largely unknown. In E. coli the lipoproteins are associated  
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Figure 33: TbpB detection in crosslinked samples of TbpB mutants. Gonococcal 
strains FA19 (wild type) and MCV814 (HA4-TbpB mutant) were grown under iron-
depleted conditions in the presence of photo-activable cross-linkers. Cultures were UV 
irradiated and whole cell lysates were prepared. Proteins were separated by SDS-PAGE 
and transferred to nitrocellulose. TbpA was detected by probing the blots with α-TbpA 
serum (A) and TbpB was detected by probing the blots with α-TbpB serum (B). Samples 
that were UV exposed are labeled as (+) and non-UV exposed are labeled as (-). 
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Figure 34: TbpB detection in crosslinked samples of TbpB mutants. Gonococcal 
strains FA19 (wild type) and MCV822 (HA8-TbpB mutant) were grown under iron-
depleted conditions in the presence of photo-activable cross-linkers. Cultures were UV 
irradiated and whole cell lysates were prepared. Proteins were separated by SDS-PAGE 
and transferred to nitrocellulose. TbpA was detected by probing the blots with α-TbpA 
serum (A) and TbpB was detected by probing the blots with α-TbpB serum (B). Samples 
that were UV exposed are labeled as (+) and non-UV exposed are labeled as (-). 
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with the cell surface and majority of the E. coli lipoproteins are localized to the inner 
leaflet of the outer membrane, on the periplasmic side (166). Many of these proteins are 
transported through the inner membrane with the help of the general secretory pathway. 
The Sec pathway that transports unfolded proteins into the periplasm consists of multiple 
subunits. Proteins that are targeted to the Sec system have an N-terminal signal sequence, 
with the lipoprotein signal II (lipoprotein peptidase cleavage site ) being unique due to 
the cysteine residue. This signal sequence is responsible for targeting lipoproteins across 
the inner membrane. Unmodified prolipoprotein is processed in a sequential manner to 
form mature lipoprotein. (81, 235).  The ABC transporter LolCDE binds these 
lipoproteins in the inner membrane, releases them to LolA in the periplasm. LolA binds 
at the lipid moiety of the protein, transports it through the periplasm and passes it onto to 
LolB. LolB, situated at the periplasmic side of the outer membrane, incorporates the 
lipoprotein into the outer membrane (210).  
In the Gram-negative bacteria, the Lol system is well conserved (234). However, 
Neisseria possesses only some of the Lol protein homologues. Since lipoproteins do 
localize to the outer membrane in Neisseria, it is not known how the lipoproteins are 
transported from the inner membrane to the outer membrane and then flipped over to the 
outer leaflet of the outer membrane, unlike in E. coli.  
 
In this study, we found that the TbpB mutant lacking the lipobox was released and 
present extracellularly after transport across the outer membrane; with the non-lipidated 
TbpB being retained less on the cellular surface. This indicates that the lipid moiety is 
essential for TbpB to be tethered to the outer leaflet of the outer membrane and lipid 
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modification was not necessary for transportation of TbpB into the extracellular matrix. 
However, the LSAC motif (lipobox) of TbpB is necessary and sufficient for lipidation as 
suggested by the palmitate labeling experiments. The cross-linking data showed the 
presence of interaction between TbpA and mutated TbpB (from the LSAC mutant). The 
presence of an interaction of TbpA with non-lipidated TbpB, suggests that this interaction 
is not dependent on lipidation of TbpB and the small amount of mutated TbpB present on 
the cellular surface or in the extracellular mileu, is still capable of interacting with TbpA, 
by the virtue of its affinity for TbpA. The surface-exposure of TbpB was important since 
lipid-modified TbpB, in the TbpA L9HA background, could not grow on transferrin as a 
sole source of iron. In the transferrin mediated iron utilization the non-lipidated TbpB is 
not able to assist TbpA for acquiring iron from transferrin; this could be due to its 
reduced presence on the cellular surface or the non-tethering of the lipoprotein on the 
outer membrane. 
 
Though the poly-glycine stretch is only 4 amino-acids long, the deletion mutation 
in this conserved region brought up some interesting findings. The protease accessibility 
assay and solid-phase transferrin binding assay confirmed that the glycine deleted TbpB 
remained surface exposed. The Δgly mutated TbpB was lipidated as confirmed by the 
palmitate-labeling experiments. The TbpA-TbpB interaction was not affected by the 
deletion of the poly glycine stretch in TbpB, however the same mutation when expressed 
in the TbpA
- 
background showed reduced growth in presence of transferrin. This 
indicates that the mutated TbpB is deficient in transferrin-iron utilization. These findings 
imply an important role of this poly-glycine region in TbpB and its function.  
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This sort of glycine-rich domain is also found in surface exposed lipoprotein (also 
a subtilisin-autotransporter) SphB1, in Bordetella pertussis. The N-terminal located 
glycine-rich and proline-rich sequences facilitate the surface presentation of the 
lipoproteins and the 14 residue long Glycine stretch is also hypothesized to be important 
in targeting the lipoprotein to the outer membrane. Several other surface lipoproteins, 
including Neisseria meningitidis TbpB and LbpB, hemoglobin (HpuA) receptor contain 
Gly-rich motifs following the modified Cys residue that are reminiscent of the Gly-rich 
stretch of SphB1(112, 114, 159). It is probable that such motifs are involved in the 
surface presentation of these lipoproteins. Therefore, the short glycine-rich region could 
function as an outer membrane localization signal, and may contribute to the surface 
presentation and/or stability of gonococcal TbpB. 
 
Data presented in a previous study indicated that both the N- and C-terminal 
halves of gonococcal TbpB have the capacity to bind Tf, consistent with internal 
sequence conservation of TbpB (62). The analysis identified internally homologous 
regions within N- and C-terminal halves of TbpB. Homologous domains in N-terminal 
and C-terminal halves of TbpB were targeted for HA insertion mutagenesis (figure 1). 
The TbpB mutants with HA4 and HA8 insertions were similar with regard to surface 
binding and iron internalization. Interruption of either region in TbpB reduced transferrin 
binding and completely eliminated all known biological functions of gonococcal TbpB 
(62). These mutants showed a dissimilar phenotype when they were analyzed through 
crosslinking assays. The HA4 mutant showed similar interaction pattern to the wildtype 
strain. It seems that the regions of TbpB, targeted for HA insertions, are less accessible 
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and located within domains that could be partially hidden by other parts of the protein in 
vivo. Therefore the insertion mutations did not disrupt the interaction between the 
transferrin binding proteins. The HA8 TbpB mutant showed no diminishing of wild type 
TbpA and TbpB being detected after crosslinking when compared to the crosslinked 
condition and the wild type strain. This result indicates that in vivo the C-lobe of TbpB 
may participate in interacting with TbpA and iron import. These results highlight the 
critical contributions that each of these regions provides in the wild-type functions of 
gonococcal TbpB. 
Recent structural characterization of the neisserial iron import machinery has 
helped refine our understanding of the manner in which TbpA and TbpB interact with 
human transferrin during transferrin mediated iron acquisition. Human transferrin is a 
bilobed glycoprotein (80 kDa) with each lobe consisting of two subdomains which form 
the cleft: N1, N2, C1 and C2. Human transferrin interacts with TbpA and TbpB solely 
through the C lobe. Whereas TbpA binds to both ferrated and deferrated forms of human 
transferrin, TbpB has a strong preference for human transferrin with iron bound in the C 
lobe (151). TbpB, which is tethered to the cell surface by an unstructured polypeptide 
chain, is able to preferentially interact with iron-loaded human transferrin. TbpB 
functions in selecting and capturing only those human transferrin entities, which are able 
to provide iron on the cell surface of the bacteria. Recent X-ray, SAXS and EM structures 
enabled in the study the TbpA-TbpB-(holo)hTf complex (150, 151). This triple complex 
showed presence of an enclosed chamber, formed at the union of the three protein 
partners such that TbpA and TbpB associate with different regions of the human 
transferrin C lobe; to allow for iron transport (151). Therefore TbpB is important 
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functionally to identify the iron-loaded and usable forms of human transferrin and to 
efficiently sequester iron released from human transferrin and directionally transport it to  
the TbpA barrel (through the formation of a potential iron chamber). 
 
It has been shown in meningococcal TbpB, there is a presence of relatively 
unstructured N-terminal anchor peptide (composed of amino acids 2-40), which is 
associated with the C-terminal lobe of TbpB (236). It has been demonstrated that the 
presence of the N-terminal anchor peptide region on TbpB is required for interacting with 
TbpA in presence of transferrin.  When the N-terminal lobe of TbpB binds transferrin, it 
displaces the anchor peptide from its interaction with the C-terminal lobe. This brings 
conformational changes in the anchor peptide, such that it moves the TbpB-Tf complex 
closer on the outer membrane, so that it is able to interact with “activated” TbpA (bound 
to TonB) (236). The anchor peptide region could extend TbpB sufficiently from the outer 
membrane surface to facilitate capture of iron-loaded transferrin in the presence of 
surface materials (193). 
 
These observations when extrapolated to our study indicate that the poly glycine 
region could function as an anchor region in gonococcal TbpB. The presence of the 4 
glycine residues could be important in modulating the position of the TbpB (relative to 
the outer membrane surface) and the formation of secondary structural features. These 
secondary conformations could potentiate an interaction with TbpA. The glycine deletion 
TbpB mutant was deficient in growth in presence of transferrin as a sole source of iron, 
because the TbpB was impaired in its ability to interact with TbpA subsequent to human 
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transferrin binding; thereby not allowing the iron internalization through the TbpA β-
barrel conduit.  
Through our study we have highlighted the functional importance of the two 
conserved regions (LSAC motif and the poly-glycine region) of gonococcal TbpB. The 
evidence presented here helps us to better understand the interactions occurring between 
TbpA-TbpB-human transferrin. This data provides a deeper understanding of the 
structural and functional aspects of two conserved regions in gonococcal TbpB.  
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CHAPTER 6: SUMMARY AND PERSPECTIVES 
 
Pathogenic bacteria, such as Neisseria, have specific outer membrane receptors 
that bind to the host's glycoprotein transferrin. Transferrin is 80 kDa in molecular weight 
and large enough that it cannot pass through the bacterial outer membrane. Therefore, 
additional steps are required to remove iron from transferrin at the surface of the outer 
membrane. Extraction of the iron from transferrin is brought about by TbpA-TbpB, the 
two members of the transferrin-iron acquisition pathway. The mechanism of transferrin–
iron acquisition by N. gonorrhoeae has been the subject of a great deal of study. The 
transferrin-iron acquisition system is composed of TbpA and TbpB protein members. 
TbpA, the TonB-dependent transporter, is the essential member and the necessary portal 
for iron travel through the outer membrane (52). TbpB, the surface-tethered lipoprotein, 
is important for increased efficiency of the iron acquisition system (1, 62). The 
gonococcal Tbp proteins are expected to interact through their interaction 
domains/residues. The precise mechanism and nature of interaction between the 
transferrin binding proteins is still poorly understood. The studies presented here helped 
in understanding the interaction phenomenon between the transferrin binding proteins 
and the importance of specific conserved regions in TbpA and TbpB in the overall 
process of transferrin mediated iron acquisition.  
The iron acquisition process in N. gonorrhoeae can conceptually be divided into 
the following steps: recognition and binding of holo-transferrin at the TbpA/TbpB 
surface; release of iron from transferrin and removal of apo-transferrin from TbpA 
surface using TonB derived energy; passage of “free iron” through the β-barrel of TbpA; 
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binding of the iron at the periplasm by FbpA (which is a part of an ABC transport 
system); and finally the passage of iron to the cytosol with the help of FbpB and FbpC. 
One of the aims of our study was to investigate the iron binding and extraction properties 
of TbpA, specifically the conserved EIEYE motif in the TbpA plug domain. We also 
investigated the interactions between TbpA and TbpB and study the importance of TonB 
derived energy and ligand on these interactions. TbpB shares similarity with other 
surface-exposed lipoproteins and the presence of an accessory lipoprotein is one of the 
properties that makes the transferrin-iron acquisition system different from the 
siderophore mediated iron acquisition. We studied the contribution of two conserved 
regions in the TbpB protein (the LSAC and poly-glycine region) and their contribution to 
interaction between the transferrin binding proteins. 
Recently, the crystal structures of components of the meningococcal transferrin–
iron uptake system were reported (151, 189). The published reports indicate that TbpA is 
one of the largest TonB-dependent transporters. TbpA consists of an N-terminal globular 
plug domain loop that occluded the barrel pore and C-terminal β-barrel domain, 
comprised of 22 β-strand transmembrane-spanning domains, with surface exposed loops. 
Previous studies have suggested the importance of TbpA in transferrin utilization (238), 
with the plug domain being critical for transferrin-iron acquisition and specifically 
functioning in iron binding and uptake (154). Binding of Fe
3+
-siderophore complexes to 
similar plug domains in outer membrane transporters during iron internalization has been 
reported for E. coli receptors FepA and FhuA, which indicates an important role for these 
plug domains in iron transport (69, 116, 215). Through sequence analysis it was shown 
that in the plug domain of TbpA, sequence EIEYE (118–122) is highly conserved. In a 
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triple-alanine substitution mutant of tbpA (EIAAA 118–122) there was an 80% reduction 
in transferrin-bound iron utilization (although the mutant binds transferrin with wild type 
affinity) (154). This shows the importance of the TbpA-plug sequence EIEYE in 
transferrin-iron utilization by gonococci. We hypothesized that iron released from 
transferrin at the TbpA surface interacts and binds with this plug sequence (EIEYE) and 
is subsequently transported through the β-barrel of TbpA. Sequestration of  Fe3+ by the 
TbpA-plug supports the notion that the ferric iron must always remain chelated and 
controlled throughout the transport process. Observations from the first part of this study 
confirm that the EIEYE sequence in the wild-type TbpA plug binds Fe
3+
 during the outer 
membrane transport process.  This work has provided in-depth knowledge about 
transferrin-iron internalization and is the first report of the expression/isolation of the 
recombinant wild-type TbpA plug.  The binding event between the sequence EIEYE and 
Fe
3+
 is also supported by in silico modeling, depicting this sequence to be a part of a 
flexible loop that can reorganize more easily. The models also predict another important 
conserved sequence, which is surface exposed, as an important region for transferrin-iron 
utilization and shows a considerable conformational change between the wild type and 
recombinant plug. This ‘top hat’ region could act as a secondary recognition site for 
transferrin interaction during iron internalization process, and this observation needs 
further studies to be confirmed. 
 
The gonococcal Tbp proteins are expected to work together during the transferrin-
iron acquisition process, particularly in the presence of transferrin. The transferrin 
binding proteins function together as a unit to acquire iron from transferrin but the nature 
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in which they interact with transferrin is different for both of the proteins. In the second 
part of this study we studied the interaction between the transferrin binding proteins by 
utilizing crosslinking assays that included the use of photo crosslinkers. Our results 
demonstrate that photo-crosslinking altered TbpB size and migration and was dependent 
on the presence of TbpA. Previous studies using an HA epitope tagging approach had 
been reported to probe the regions of TbpB and TbpA that are important for transferrin 
binding and transferrin–iron uptake in gonococci (62, 123, 154). None of the HA epitope 
insertion mutants in surface exposed loops of TbpA and TbpB deviated from the 
interaction pattern that was seen in the wild type strain and the mutations did not impact 
the mobility of cross-linked TbpB. The addition of transferrin to wildtype strain did not 
change the interaction pattern of the transferrin binding proteins. Addition of transferrin 
to the de-energized mutant caused a change in TbpB migration after cross-linking. This 
result indicates that when ligand is bound tightly and irreversibly to TbpA, the surface 
accessibility and perhaps conformation of TbpB is altered. Recent structural studies of 
TbpA-TbpB-ligand triple complex (151) illustrate that transferrin binding proteins bind 
ligand through unique, non-over lapping binding sites such that TbpA and TbpB do not 
interact. Our in vivo studies suggest that in presence of ligand, de-energized TbpA does 
not interact with TbpB. While the structures have significantly advanced our 
understanding of the role of TbpA and TbpB in transferrin-iron acquisition pathway, 
more studies are needed to fully elucidate the role of TbpB and its interactions with 
TbpA.  
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The last aim of the current study was to determine the contribution of two 
conserved regions (the LSAC lipobox and the poly-glycine region), and the region with 
the HA4 and HA8 epitope insertions within TbpB (figure 1) to the interactions between 
the transferrin binding proteins. In a previous study, homologous domains in N-terminal 
and C-terminal halves of TbpB were targeted for HA insertion mutagenesis (figure 1) 
(62). The HA4 and HA8 TbpB insertion mutants were similar in surface binding and iron 
internalization. Both of these mutants showed reduced transferrin binding and completely 
eliminated all known biological functions of gonococcal TbpB (62). These mutants were 
dissimilar in their interaction analysis through crosslinking assays. The HA4 mutant 
showed similar interaction pattern to the wildtype strain, with no reduction in wildtype 
sized TbpA and TbpB. It seems that the region of TbpB, targeted for HA4 insertion, is 
located within a domain that could be partially hidden by other parts of the protein in vivo 
and the insertion did not disrupt the interaction between the transferrin binding proteins. 
The HA8 TbpB mutant showed no diminishing of wild type TbpA and TbpB being 
detected after crosslinking when compared to the crosslinked condition and the wild type 
strain. This result indicates that in vivo the C-lobe of TbpB may participate in interacting 
with TbpA and subsequently iron import. These results highlight the critical contributions 
that each of these regions provides in the wild-type functions of gonococcal TbpB. 
We demonstrated that the lipobox, but not the glycine-rich domain, is required for 
lipidation of TbpB and tethering to the outer membrane. These results indicate that TbpB 
transport is lipoprotein-specific mechanism. When these mutant TbpB proteins were 
expressed in a strain simultaneously expressing a mutant form of TbpA that requires 
TbpB for iron acquisition, growth on transferrin was either completely abrogated or 
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dramatically diminished. We conclude that surface localization of TbpB is required for 
optimal performance of the transferrin-iron acquisition system, while the presence of the 
poly-glycine stretch near the amino-terminus of TbpB contributes significantly to the 
function of the transporter. These results provide important insights into the functional 
roles of two conserved regions of TbpB, furthering our understanding of this critical iron 
uptake system. Furthermore these observations may be broadly applied to other lipid-
modified receptor proteins of the pathogenic Neisseria. 
In search of a cross-protective gonococcal vaccine, focus is on receptors that are 
necessary for nutrient acquisition. One such nutrient is iron. Iron acquisition is critical for 
the bacterial survival in vivo and in tissue culture systems, and bacterial components 
involved in the iron acquisition process could represent conserved targets for vaccine 
development. Members of the transferrin-iron acquisition pathway, TbpA and TbpB are 
prospective vaccine candidates because TbpA and TbpB are not subject to high frequency 
phase or antigenic variation like other virulence factors of Neisseria gonorrhoeae, they 
are expressed by all gonococcal isolates (132), and they are required for initiation of 
infection in human male volunteers (53). The transferrin binding proteins of Neisseria 
gonorrhoeae and Neisseria meningitidis are similar in sequence (1, 47), suggesting that a 
vaccine comprised of these antigens could potentially protect against both gonococcal 
and meningococcal infections. In Neisseria meningitidis it has been shown that antibodies 
against transferrin binding proteins are bactericidal, cross-reactive and block the binding 
of transferrin (59, 177, 229). In Neisseria gonorrhoeae antibodies against recombinant 
gonococcal transferrin binding proteins are bactericidal and cross-reactive (164, 165). 
These observations highlight the potential that the transferrin binding proteins possess to 
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be developed as vaccine candidates. Identification of novel and important targets in TbpA 
and TbpB will aid in the development of vaccines against Neisseria infection.  
Our results presented here, help in elucidating the involvement of both the 
transferrin binding proteins in the transferrin mediated iron acquisition pathway. With 
this knowledge we have gained more in-depth understanding of the requirements for a 
functional interaction between gonococcal TbpA and TbpB. By looking at the structural 
and functional properties of the gonococcal transferrin receptor, we have a better 
understanding of mechanisms by which the gonococcus acquires iron from human 
transferrin. Knowledge about the transferrin receptor proteins will give us a better 
understanding as to how these proteins function and the characteristics of the receptor 
that are expressed in the bacteria. This knowledge is essential for the rational design of a 
vaccine comprised of one or both of the transferrin binding proteins. Information derived 
about this receptor may be extended to other transferrin receptors such as those expressed 
in N. meningitidis, Moraxella catarrhalis, and Haemophilus influenzae.  
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